oxycodone has been researched along with Addiction, Opioid in 407 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (0.98) | 18.7374 |
| 1990's | 3 (0.74) | 18.2507 |
| 2000's | 50 (12.29) | 29.6817 |
| 2010's | 241 (59.21) | 24.3611 |
| 2020's | 109 (26.78) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Fan, X; Mulligan, MK; Redei, EE; Sharp, BM | 1 |
| Barnachea, L; McGann, M; Sacco, A | 1 |
| Borges, C; Cai, X; Ferris, CF; Iriah, SC; Kulkarni, PP; Madularu, D; Shalev, U | 1 |
| DiNardi, M | 1 |
| Kim, T; Lightfoot, NJ; Sara, RA; Zhou, CE | 1 |
| Chalangal, J; Mazid, S; Milner, TA; Windisch, K | 1 |
| Caird, MS; Hong, RA; Leis, A; Li, Y; Robbins, C; Swallow, J | 1 |
| Marwaha, S | 1 |
| Detwiller, KY; Farrell, NF; Geltzeiler, M; Mace, JC; Pailet, J; Pandrangi, VC; Scott, BL; Smith, TL | 1 |
| Calderon, SN; Fang, L; Fields, E; Li, W; Nallani, SC; Roca, RA; Sahajwalla, CG; Xu, Y; Zhao, L; Zineh, I | 1 |
| Hohmann, AG; Iyer, V; Pacheco, R; Woodward, TJ | 1 |
| DeFries, T; Leyde, S; Pratt, L; Suen, L | 1 |
| Berghella, V; Cao, CD; Dayaratna, S; Felder, L; Konys, C; Mercier, R; Weerasooriya, N | 1 |
| Ågren, G; Fugelstad, A; Hjelmström, P; Ramstedt, M; Thiblin, I | 1 |
| Banerjee, G; Beachler, DC; Boulanger, L; Garg, R; Hall, K; Li, L; Walker, AM; Yuce, H | 1 |
| Fahmy, C; Jackson, DB; Testa, A | 1 |
| Biggs, N; da Gama, M; Evans, J; Lam, T; Lubman, DI; Nielsen, S; Stevens, J; Xia, T | 1 |
| Fischer, B; Gomes, T; Huang, A; Jones, W; Kurdyak, P; Littleford, S; Paracha, N; Rudoler, D | 1 |
| Daunert, S; Deo, S; Dikici, E; Peyravian, N; Sun, E; Toborek, M | 1 |
| Brown, O; Crouss, T; Dahl, ME; Dancz, CE; Eckhardt, S; Halder, G; Hoover, M; McDonald, KC; Pan, C | 1 |
| Basam, M; McLemore, EC; Rudikoff, A; Thuraisingham, D; Tran-McCaslin, M | 1 |
| Borza, T; Byrne, A; Farhat, W; Finup, J; O'Kelly, F; Sherrer, R; Su, R | 1 |
| Acharya, M; Dayer, L; Hayes, CJ; Li, C; Martin, BC; Painter, JT | 2 |
| Buxton, JA; Hategeka, C; Hayashi, K; Karamouzian, M; Kerr, T; Milloy, MJ; Nosova, E | 1 |
| Castillo, F; Comer, SD; Evans, SM; Foltin, RW; Jones, JD; Luba, RR; Mogali, S | 1 |
| O'Meara, A; O'Sullivan, DM; Ramaseshan, AS; Tunitsky-Bitton, E | 1 |
| Al-Hasani, R; Baldwin, JW; Conway, SM; Dougherty, JD; Madasu, MK; Maloney, SE; McCullough, KB; Mikati, MO; Minakova, E; Swift, RG | 1 |
| Budde, MD; Chiariello, R; Glaeser, BL; McCarthy, C; Olsen, CM; Shah, AS; Stemper, BD | 1 |
| Fouilhé Sam-Laï, N; Jouanjus, E; Khouri, C; Revol, B; Robert, M | 1 |
| Caritis, S; Krans, E; LaSorda, KR; Lim, G; Rosario, BL; Wong, CA | 1 |
| Cassella-Mclane, G; Choucair, I; Durant, TJS; El-Khoury, JM; Vera, MA; Villalba, CF | 1 |
| Biggs, N; Cheng, O; da Gama, ME; Evans, JD; Kabu, K; Lam, T; Lubman, DI; Nielsen, S; Stevens, JA; Treloar, M; Xia, T | 1 |
| Abiraman, K; Casey, E; Chang, YH; Copits, BA; Creed, MC; Earnest, T; Gereau, RW; Kravitz, AV; Kumar Pitchai, D; Li, JN; Moore, T; Pareta, R; Sackey, JT; Slivicki, RA; Tooley, J; Vachez, YM; Wolf, DK | 1 |
| Amgott-Kwan, AT; Zadina, JE | 1 |
| Bubser, M; Duncan, E; Gould, RW; Jones, CK; Lindsley, CW; Teal, LB | 1 |
| Dailey Govoni, T; Green, JL; Rajagopal, V; Rodriguez, RD | 1 |
| Black, J; Dart, R; Ellis, M; Iwanicki, J; Jewell, J; Olsen, H | 1 |
| Amagata, T; Haraguchi, K; Higuchi, Y; Inaba, I; Isaka, H; Kawashiri, T; Kihara, T; Kobayashi, D; Kurata, S; Nishina, T; Ota, A; Shimazoe, T; Takaki, J; Tanaka, T; Tatsuma, K | 1 |
| Balgobin, S; Balk, EM; Gala, RB; Gupta, A; Hobson, D; Jeppson, PC; Matteson, KA; Meriwether, KV; Olivera, C; Schimpf, MO; Singh, R; Thompson, JC; White, AB | 1 |
| Bouvy, ML; Dahan, A; Gademan, MGJ; Nelissen, RGHH; Rosendaal, FR; van Brug, HE; van Dorp, ELA | 1 |
| Allen, MI; Banks, ML; Cornelissen, JC; Nader, MA; Newman, AH; Woodlief, K | 1 |
| Diaz, DM; DiLeone, RJ; Foscue, E; Taylor, JR; Thompson, SL; Trinko, R | 1 |
| Barrett, JE; Inan, S; Shekarabi, A | 1 |
| Benner, C; de Guglielmo, G; Di Ottavio, F; Dirik, S; Doyle, MR; George, O; Martin-Fardon, R; Martinez, AR; Pascasio, G; Qiao, R; Telese, F | 1 |
| Berna, C; Eikemo, M; Ernst, G; Garland, EL; Jensen, EN; Leknes, S; Løseth, GE; Meier, IM; Trøstheim, M; Ørstavik, N | 1 |
| Dennett, JM; Gonsalves, GS | 1 |
| Austin, PC; Everett, K; Gomes, T; Juurlink, DN; Li, P; Mamdani, M; Paterson, JM; Ray, JG; Zipursky, JS | 1 |
| Bouvy, M; Heringa, M; Jansen-Groot Koerkamp, E; Kruijtbosch, M; Numans, M; van Thiel, G | 1 |
| Dart, RC; Haanschoten, EE; Iwanicki, J; Severtson, SG | 1 |
| Hartmann, GE; Sethi, R | 1 |
| Azani, D; Barahona, JA; Barrera, M; Cahill, CM; Dong, TS; Hakimian, JK; Jacobs, JP; Lagishetty, V; Lee, S; Mittal, N; Severino, AL; Tiwari, S; Walwyn, WM | 1 |
| Flores, EJ; Heng, M; Kontos, NJ; Nisavic, M; Quijije, N | 1 |
| Elvig, SK; Fegan, KN; Huynh, DT; Lee, S; McGovern, DJ; Phillips, AG; Ro, K; Root, DH | 1 |
| Brewin, LW; Coelho, MA; Ferdousian, S; Gabriella, I; Lieberman, D; Stailey, N; Swauncy, I; Szumlinski, KK; Tran, T | 1 |
| Comer, SD; Jones, JD; Manubay, JM; Martinez, S; Mogali, S; Mumtaz, M; Sherwin, E | 1 |
| Fan, XY; Shi, G; Zhao, P | 1 |
| Hill, MR; Hopkins, MR; Knezevic, CE | 1 |
| Allen, B; Kunins, HV; Paone, D; Tuazon, E | 1 |
| Chang, KM; Doubeni, CA; Gross, R; Harris, RA; Kranzler, HR | 1 |
| Beheshti, D | 1 |
| Arnold, C; Bui, T; Dooley, M; Hopkins, RE; Magliano, D | 1 |
| Blendy, J; Collins, D; Kreek, MJ; Zhang, Y | 1 |
| Bergman, J; Doyle, RJ; Kangas, BD; Porter, EN; Withey, SL | 1 |
| Martin-Fardon, R; Matzeu, A | 1 |
| Bavli, I | 1 |
| Carrette, LLG; de Guglielmo, G; George, O; Kallupi, M; Kononoff, J; Palmer, AA; Schweitzer, P; Solberg Woods, LC | 1 |
| Kangas, BD; Leonard, MZ | 1 |
| Brandt, L; Comer, SD; Jones, JD; Levin, FR; Manubay, JM; Martinez, S; Mogali, S; Ramey, T | 1 |
| Barr, GA; DeSalle, MJ; Deutsch, HM; Eisch, AJ; Zanni, G | 1 |
| Abela, GP; Duddy, P; Fahy, O; Irwin, R; Stanescu, S; Tan, T | 1 |
| LeClair, C; McDonald, JV; Meyer, A | 1 |
| Bhatia, S; Bonner, JA; Carroll, WR; Dobelbower, MC; McCammon, S; McDonald, AM; McGwin, G; Nabell, L; Spencer, SA; Swain, TA; Willey, CD; Yang, ES | 1 |
| Gazelka, H; Geyer, HL; Mesa, R | 1 |
| Hasan, L; Jildeh, TR; Khalil, LS; Matar, RN; Moutzouros, V; Okoroha, KR; Schwartz, K | 1 |
| Abbaraju, S; Amin, R; Baruffaldi, F; Gilger, B; Gradinati, V; Laudenbach, M; Pravetoni, M; Velagaleti, P | 1 |
| Bonk, R; Kemp, J; Lanter, J; Miller, RJ; Niblo, C; Shelton, J | 1 |
| Aritomi, H; Asaki, T; Chiba, H; Fujita, M; Furue, Y; Kanemasa, T; Koike, K; Matsumoto, T; Matsuzaki, T; Muramoto, M; Nakamura, A; Shimada, S; Shimada, T; Takase, K; Watari, R; Yasufuku, K | 1 |
| Ackerman, G; Krock, K; Nickley, J; Pesce, A; Thomas, R; Tran, K | 1 |
| Brown, CR; Chen, Z; Desai, ND; Groeneveld, PW; Khurshan, F | 1 |
| Accetturo, C; Pravetoni, M; Raleigh, MD | 1 |
| Allen, B; Harocopos, A; Nolan, ML; Paone, D | 1 |
| Freeman, KB; Pareek, T; Patel, TR; Prisinzano, TE; Schrock, HM; Williams, BC; Zamarripa, CA | 1 |
| Auld, MC; Horwitz, JR; Lukenchuk, B; McClelland, L | 1 |
| Clark, AR; Gowen, A; Guda, C; Koul, S; Lisco, SJ; Odegaard, KE; Pendyala, G; Sankarasubramani, J; Schaal, VL; Xiao, P; Yelamanchili, SV | 1 |
| de Bruijne, M; Jongerden, I; Klopotowska, JE; Langelaan, M; Moesker, M; Schutijser, BCFM; Wagner, C | 1 |
| Lapeyre-Mestre, M; Micallef, J; Pradel, V; Soeiro, T | 1 |
| Aiken, T; Glover, C; Lawson, EH; Livingston-Rosanoff, D; Paulson, M; Rademacher, B; Skelton, P | 1 |
| Chartoff, E; Constantino, N; Lintz, T; Mavrikaki, M; Page, S | 1 |
| Amioka, EC; Dart, RC; Geoffrey Severtson, S; Iwanicki, JL; Kreider, SED; Margolin, ZR | 1 |
| Black, JC; Dart, RC; Iwanicki, JL; May, KP; Schwarz, J | 1 |
| Buchbinder, R; Lin, CC; Maher, CG; Mathieson, S; McLachlan, AJ; Pearson, SA; Underwood, M; Wertheimer, G | 1 |
| Ali, N; Babalonis, S; Coe, MA; Fanucchi, LC; Lofwall, MR; Nuzzo, PA; Sloan, PA; Walsh, SL | 1 |
| Alderete, JA; Cahill, CM; Evans, CJ; Kibaly, C; Law, PY; Liu, SH; Nasef, HS | 1 |
| Grucza, R; Salas, J; Scherrer, JF; Tucker, J; Zhang, Z | 1 |
| Cochran, G; Cox, N; Gadd, S; Kenney, A; Samuelson, J; Turner, K | 1 |
| Connors, NJ; Kim, HK; Mazer-Amirshahi, M; Motov, S | 1 |
| Blendy, JA; Carpenter, MD; Heller, EA; Manners, MT | 1 |
| Hagiwara, Y; Lockman, K; Nguyen, TP; Pies, C | 1 |
| Fazel, S; Luciano, S; Paljarvi, T; Quinn, PD; Strang, J | 1 |
| Black, JC; Bletz, A; Dargan, PI; Dart, RC; Hockenhull, J; Margolin, Z; Olson, R; Wood, DM | 1 |
| Davis, CS | 1 |
| Park, S; Powell, D | 1 |
| Black, JC; Dart, RC; Iwanicki, JL; Olsen, HA; Severtson, SG | 1 |
| Birchall, CL; Kunselman, AR; Maines, JL; Pauli, JM; Stetter, CM | 1 |
| Barr, GA; DeSalle, MJ; Deutsch, HM; Dougher, AA; Eisch, AJ; Robinson-Drummer, PA; Sullivan, RM; Teplitsky, D; Vemulapalli, A; Zanni, G | 1 |
| Bruehl, S; Franklin, AD; Luckett, T; Nelson, SD; Patrick, SW; Potts, AL; Qu'd, D; Quinn, EE; Stone, AL | 1 |
| Leri, F; Limebeer, CL; Minhas, M; Parker, LA; Strom, E | 1 |
| Beardsley, PM; Carper, M; Contreras, KM; Damaj, MI; Walentiny, DM | 1 |
| Boyce, H; Frost, M; Kelsh, D; Kim, MJ; Kinjo, M; Li, Z; Lionberger, R; Luke, M; Natarajan, K; Raofi, S; Sun, D; Zhao, L | 1 |
| Coe, MA; Lofwall, MR; Nuzzo, PA; Vessels, V; Walsh, SL | 1 |
| Babalonis, S; Comer, SD; Hatton, KW; Jones, JD; Lofwall, MR; Manubay, J; Nuzzo, P; Walsh, SL; Whittington, RA | 1 |
| Baruffaldi, F; Hamid, FA; King, SJ; LeSage, MG; Pentel, PR; Pravetoni, M; Raleigh, MD; Saykao, A; Winston, S | 1 |
| Huang, JC; Iqbal, SN; Kawakita, T; Mokhtari, NB; Saeed, H | 1 |
| Dasgupta, N | 1 |
| Baehr, CA; Hamid, FA; Hart, GT; Huseby Kelcher, AM; Pravetoni, M | 1 |
| Askalsky, P; Comer, SD; Jones, JD; Madera, G; Mogali, S | 1 |
| Jones, CM; Mack, KA; McClure, RJ | 1 |
| Buchhalter, AR; Di Fonzo, CJ; Eldon, MA; Henningfield, J; Lu, L; Odinecs, A; Siddhanti, S; Webster, L | 1 |
| Hernandez, NM; Parry, JA; Taunton, MJ | 1 |
| Comer, SD; Johnson, KW; Jones, JD; Madera, G; Manubay, J; Metz, VE; Mogali, S; Segoshi, A; Sullivan, MA | 1 |
| Diaz, CJ; Goode, PA; Leonard, JB; Nair, V; Penoyar, JB | 1 |
| Aminian, P; Elliott, RA; Findakly, D; Hardidge, A; Taylor, SE; Tran, T | 1 |
| Brown, CN; Coelho, MA; Healy, AF; Jimenez, SM; Kippin, TE; Szumlinski, KK | 1 |
| da Silva, FS; do Carmo, JM; Edwards, SR; Freeman, KB; Hall, JE; Kapanda, CN; McCurdy, CR; McLendon, HW; Naylor, JE; Negus, SS; Qureshi, HN; Sufka, KJ; Townsend, EA | 1 |
| Besharat, A; Green, JL; Haynes, C; Vosburg, SK | 1 |
| Fischer, B; Kurdyak, P; Vojtila, L | 1 |
| Clucas, D; Filshie, R; Nandurkar, H; Robson, KJ | 1 |
| Burns, L; Degenhardt, L; Dobbins, T; Gisev, N; Hall, WD; Pearson, S; Roxburgh, A | 1 |
| Akbarali, HI; Dewey, WL; Gonek, M; Henderson, G | 1 |
| By, K; Hwang, CS; Keeton, SL; Kornegay, CJ; Levenson, MS; Ly, T; McAninch, JK; Secora, A | 1 |
| Bi, GH; Boateng, C; Cao, J; Gao, JT; Gardner, EL; He, Y; Newman, AH; Xi, ZX; You, ZB | 1 |
| Fleming, AB; Mayock, SP; Saim, S | 2 |
| Brooks, A; Kominek, C | 1 |
| Baruffaldi, F; Carroll, FI; Comer, SD; Langston, TL; Laudenbach, M; Navarro, HA; Pentel, PR; Peterson, SJ; Pravetoni, M; Raleigh, MD; Runyon, SP; Winston, S | 1 |
| Cicero, TJ; Dart, RC; Green, JL; Kurtz, SP; Parrino, MW; Severtson, SG; Vosburg, SK | 1 |
| Dietze, P; Jauncey, M; Livingston, M; Salmon, AM | 1 |
| Casavant, MJ; Caupp, S; Shi, J; Spiller, HA; Steffan, J; Wheeler, KK; Xiang, H | 1 |
| Ali, R; Bruno, R; Degenhardt, L; Dobbins, T; Farrell, M; Larance, B; Lintzeris, N; Peacock, A | 1 |
| Caetano, P; Gomes, T; Henry, D; Jain, S; Paterson, JM; Sketris, I | 1 |
| Visconti, A | 1 |
| Balter, R; Bedi, G; Comer, SD; Cooper, ZD; Haney, M; Ramesh, D | 1 |
| Marom, E; Ponizovsky, AM; Schwartzberg, E; Weizman, A | 1 |
| Baruffaldi, F; Birnbaum, AK; Carroll, FI; Laudenbach, M; Pentel, PR; Peterson, SJ; Pravetoni, M; Raleigh, MD; Roslawski, MJ; Runyon, SP; Winston, S | 1 |
| Bynum, ND; Flegel, R; Grabenauer, M; Hayes, ED; Mitchell, JM; Moore, KN; White, RM | 1 |
| Buckley, NA; Cairns, R; Degenhardt, L; Dobbins, TA; Larance, B; Pearson, SA; Schaffer, AL | 1 |
| Aigner, S; Iverson, M; Kinzler, ER; Pantaleon, C; Smith, MD; Webster, LR | 1 |
| Baehr, C; Baruffaldi, F; Carter, P; Laudenbach, M; Pravetoni, M; Robinson, C; Seelig, D | 1 |
| Boucherie, Q; Lapeyre Mestre, M; Lepelley, M; Mallaret, M; Micallef, J; Ponté, C; Pradel, V | 1 |
| Brooke Lerner, E; Fumo, N; Peterson, BL; Schreiber, S | 1 |
| Beardsley, PM; Walentiny, DM; Wiebelhaus, JM | 2 |
| Bau, GE; Dart, RC; Dasgupta, N; Lebin, JA; Murphy, DL; Severtson, SG | 1 |
| Chow, F; McLaughlin, G; Nivens, T; Pan, Z; Wood, C; Zaretsky, M; Zuk, J | 1 |
| Candy, B; Jones, L; Larkin, PJ; Stone, P; Vickerstaff, V | 1 |
| Broecker, JS; Hart, AM; Kao, L; Losken, A | 1 |
| Grant, Y; Hwang, CS; Janda, KD; Nguyen, JD; Taffe, MA | 1 |
| Crudele, N; Giordano, J | 1 |
| Cheng, HG; Coplan, PM | 1 |
| Blackney, KA; Edwards, DA; Kamdar, NV; Liu, CA | 1 |
| Ardid, D; Authier, N; Chenaf, C; Delage, N; Delorme, J; Eschalier, A; Kaboré, JL; Mulliez, A; Pereira, B; Zenut, M | 1 |
| Kreek, MJ; Liang, Y; Randesi, M; Yuferov, V; Zhang, Y; Zhao, C | 1 |
| Dorr, LD; McKnight, BM; Trasolini, NA | 1 |
| Beachler, DC; Coplan, PM; Walker, AM | 1 |
| Baruffaldi, F; Birnbaum, A; Gradinati, V; Hassler, C; Kelcher, AH; Laudenbach, M; Lees, A; Limkar, A; Pravetoni, M; Roslawski, M; Runyon, S | 1 |
| Guevara, M; Hofilena, D; Mikel, C; West, R | 1 |
| DiPetrillo, L; Ehrich, E; Kelsh, D; Nangia, N; Pathak, S; Puhl, MD; Setnik, B; Stanford, AD; Sun, L; Vince, B | 1 |
| Jauncey, M | 1 |
| Cook, DJ; Kaskovich, SW; Lee, MJ; Mica, MAC; Pirkle, SC; Shi, LL | 1 |
| Housman, JM; Williams, RD | 1 |
| Alpert, A; Pacula, RL; Powell, D | 2 |
| Eng, G; Wakeman, SE; Walley, AY | 1 |
| Buckley, NA; Litchfield, M; Narayan, SW; Pearson, SA; Schaffer, AL; Zheng, D; Zoega, H | 1 |
| Buvanendran, A; Calkins, TE; Culvern, C; Darrith, B; Della Valle, CJ; Gerlinger, TL; Hannon, CP; Li, J; Nam, D | 1 |
| Kaye, AD; McAnally, H; Remillard, D | 1 |
| Levy, N; Mills, P | 1 |
| Bigal, ME | 1 |
| Law, PY; Loh, HH; Tao, PL; Wang, Y; Yang, PP; Yeh, TK | 1 |
| Lim, R; Moffat, AK; Pratt, NL; Ramsay, E; Roughead, EE | 1 |
| Baruffaldi, F; Birnbaum, AK; Carroll, FI; Hassler, C; King, SJ; Pentel, PR; Pravetoni, M; Raleigh, MD; Roslawski, MJ; Runyon, SP; Winston, S | 1 |
| Chung, DY; Foster, ML; McCall, KL; Moran, MT; Nichols, SD; Piper, BJ; Shah, DT; Simpson, KJ | 1 |
| Comer, SD; Pravetoni, M | 1 |
| Blackwood, CA; Cadet, JL; Leary, M; McCoy, MT; Salisbury, A | 1 |
| Lee, R; Lee, T | 1 |
| Glazier, RE; Kling, RN | 1 |
| Butler, SF | 1 |
| Jamison, RN | 1 |
| Miller, A | 2 |
| Uddin, F | 1 |
| Coleman, J; Kirsh, K; Peppin, J | 1 |
| Apseloff, G; Colucci, SV; Harris, SC; Perrino, PJ | 1 |
| Bruera, E; Kang, JH; Lee, GW; Shin, SH | 1 |
| Anthony, JC; Deandrea, DC; Troost, JP | 1 |
| Cohen, J; Comer, SD; Cooper, ZD; Fugon, L; Jones, JD; Manubay, JM; Mogali, S; Roux, P; Sullivan, MA; Vosburg, SK | 1 |
| Steffan, RR | 1 |
| Colucci, SV; Harris, SC; Perrino, PJ; Sellers, EM | 1 |
| Comer, SD; Cooper, ZD; Jones, JD; Kowalczyk, WJ; Manubay, JM; Metz, VE; Peyser, D; Saccone, PA; Smith, ME; Sullivan, MA; Vosburg, SK | 1 |
| Cepeda, MS; Fife, D; Ma, Q; Ryan, PB | 1 |
| Clancy, C; James, L; Mazer-Amirshahi, M; Reid, N; van den Anker, J | 1 |
| Meyer, CR | 1 |
| Baer, PA; Bordman, J; Weinberg, EL | 1 |
| Chilcoat, HD; Coplan, PM; Kale, H; Landau, C; Sandstrom, L | 1 |
| Pergolizzi, JV; Raffa, RB; Taylor, R | 2 |
| Butelman, ER; Ho, A; Kreek, MJ; Mayer-Blackwell, B; Ott, J; Schlussman, SD; Zhang, Y | 1 |
| Bartlett, C; Colucci, SV; Harris, SC; Perrino, PJ; Sellers, EM; Shram, MJ; Smith, I | 1 |
| Dertadian, GC; Maher, L | 1 |
| Cicero, TJ; Ellis, MS; Kurtz, SP; Surratt, HL | 1 |
| Black, RA; Butler, SF; Cassidy, TA; DasMahapatra, P; Wieman, MS | 1 |
| Cepeda, MS; Fife, D; Kihm, MA; Mastrogiovanni, G; Yuan, Y | 1 |
| Burness, CB; Keating, GM | 1 |
| Pulia, MS; Reiff, C | 1 |
| Boston, RC; Daly, D; Linares, OA; Stefanovski, D | 1 |
| Bredenberg, S; Cai, B; Engqvist, H | 1 |
| Ben-Joseph, R; Birnbaum, HG; Kirson, NY; Michna, E; Rossiter, LF; Shei, A; White, AG | 2 |
| Fischer, B; Jones, W; Rehm, J | 1 |
| King, S | 1 |
| Narayana, A; Passik, SD; Yang, R | 1 |
| Chilcoat, HD; Coplan, P; DeVeaugh-Geiss, AM; Havens, JR; Leukefeld, CG | 1 |
| Ben-Joseph, R; Birnbaum, HG; Kirson, NY; Michna, E; Shei, A | 1 |
| Bartlett, C; Colucci, SV; Harris, SC; Perrino, PJ; Shram, M; Wang, Y | 1 |
| Distefano, MD; Laudenbach, M; Pentel, PR; Pravetoni, M; Tucker, AM; Vervacke, JS | 1 |
| Black, RA; Butler, SF; Chilcoat, HD; Coplan, PM; McNaughton, EC; Weber, SE | 1 |
| Huygen, FJ; Koopmans-Klein, G; van Dongen, VC; van Megen, YJ; Van Zundert, J; Vanelderen, PJ | 1 |
| Boikos, C; Fraser, V; Harper, S; King, NB; Richardson, R | 1 |
| Bertulli, R; Bossi, P; Granata, R; Saita, L | 1 |
| Boston, RC; Fudin, J; Linares, AD; Linares, OA; Schiesser, WE | 1 |
| Chartoff, EH; LeSage, MG; Pentel, PR; Potter, DN; Pravetoni, M; Tally, L | 1 |
| Fudin, J; Twillman, R | 1 |
| Hernandez, DO; Koob, GF; Schlosburg, JE; Vendruscolo, LF; Wade, CL | 1 |
| Ali, R; Bruno, R; Degenhardt, L; Farrell, M; Larance, B; Lintzeris, N | 2 |
| Dyer, O | 1 |
| Alexander, GC; Chang, HY; Hwang, CS | 1 |
| Drummer, OH; Gaya, S; Pilgrim, JL; Saar, E; Yafistham, SP | 1 |
| Brownstein, AJ; Buonora, M; Correa da Rosa, J; Ho, A; Kreek, MJ; Niikura, K; Ott, J; Zhang, Y | 1 |
| Degenhardt, L; Demirkol, A; Dunlop, A; Lintzeris, N; Muhleisen, P; Murnion, B; Nielsen, S | 1 |
| Bucher-Bartelson, B; Cicero, TJ; Dart, RC; Green, JL; Parrino, MW; Severtson, SG; Surratt, HL | 1 |
| Dasgupta, N; Raymond, D | 1 |
| Carlson, DR; Fleming, AB; Grima, M; Kopecky, EA; Mayock, SP; Saim, S; Varanasi, RK | 1 |
| Cicero, TJ; Ellis, MS | 2 |
| Kim, BW; Peskin, RM | 1 |
| Duse, G; Ferrari, R; Visentin, M; Zanolin, ME | 1 |
| Plotzker, DA | 1 |
| Hock, K; Mullins, ME; Scott, MG | 1 |
| Baruffaldi, F; Distefano, MD; Griffith, TS; Laudenbach, M; Mueller, DL; Pravetoni, M; Titcombe, PJ; Tubo, NJ; Vervacke, JS | 1 |
| Brigham, G; Cameron, D; Carlson, R; Daniulaityte, R; Sheth, A | 1 |
| Burke, C; Coffin, PO; Lemos, NP; Santos, GM; Visconti, AJ | 1 |
| van Amsterdam, J; van den Brink, W | 1 |
| Ali, R; Bruno, R; Cama, E; Degenhardt, L; Hordern, A; Kihas, I; Larance, B; Lintzeris, N; Peacock, A; White, N | 1 |
| Gangahar, D | 1 |
| Dolgin, E | 1 |
| Fleming, AB; Gudin, J; Kopecky, EA; Levy-Cooperman, N | 1 |
| Barrett, T; Devarakonda, K; Eisenhauer, TD; Giuliani, M; Heasley, R; Matchett, M; Morton, T; Young, JL | 1 |
| Chiravuri, S; Kaye, AD; Ruan, X | 1 |
| Dart, RC; Green, JL; Severtson, SG | 1 |
| Della Vedova, CB; Farquharson, AL; Kershaw, SG; Majumder, I; Ward, MB; White, JM; Williamson, PA | 1 |
| Ali, R; Bruno, R; Cama, E; Degenhardt, L; Larance, B; Lintzeris, N; Peacock, A | 1 |
| Ciccocioppo, R; Comer, SD; Jones, JD; Manubay, JM; Metz, VE; Mogali, S; Sullivan, MA | 1 |
| Brennan, F | 1 |
| Dahmke, H; Kullak-Ublick, GA; Kupferschmidt, H; Weiler, S | 1 |
| Babalonis, S; Elayi, SC; Jicha, CJ; Lofwall, MR; Nuzzo, PA; Walsh, SL | 1 |
| McCarthy, M | 1 |
| Baldwin, GT; Compton, WM; Jones, CM | 1 |
| Fleming, AB; Kopecky, EA; Smith, MD; Webster, LR | 1 |
| Forrester, MB; Haynes, A; Kleinschmidt, K; Young, A | 1 |
| Babalonis, S; Casselton, V; Lofwall, MR; Nuzzo, PA; Walsh, SL | 1 |
| Kopecky, EA; Nalamachu, S; O'Connor, M; Taylor, R; Vaughn, B | 1 |
| Hoback, J | 1 |
| Graziani, M; Nisticò, R | 1 |
| Butler, SF; Chilcoat, HD; Coplan, PM; Dart, RC; Haddox, JD; Harikrishnan, V; Kadakia, A; Sellers, EM | 1 |
| Campbell, CI; Chilcoat, HD; Coplan, PM; Green, CA; Janoff, SL; Perrin, NA | 1 |
| Cicero, TJ; Ellis, MS; Kasper, ZA | 1 |
| Alexander, SA; Makonahally, D | 1 |
| Babalonis, S; Elayi, SC; Lofwall, MR; Nuzzo, PA; Walsh, SL | 1 |
| Bennett, CL; Chen, B; Yang, YT | 1 |
| Davis, MP | 1 |
| Bruno, R; Degenhardt, L; Demirkol, A; Lintzeris, N; Nielsen, S | 1 |
| Cleland, CM; Palamar, JJ; Shearston, JA | 1 |
| Alexander, L; Chilcoat, HD; Coplan, PM; Harikrishnan, V | 1 |
| Pixton, G; Roland, CL; Setnik, B; Webster, L | 1 |
| Bonifazi, A; Ellenberger, MP; Gardner, E; Keck, TM; Kumar, V; Newman, AH; Pommier, E; Rais, R; Slusher, BS; Xi, ZX; You, ZB | 1 |
| Jones, CM; Lurie, PG; Muhuri, PK | 1 |
| Davis, A; Davis, K; Gerard, C; Goyal, S; Jackson, G; James, C; Loe, E; Nicolls, B; O'Rourke, MA; Shuker, C; Te Karu, L | 1 |
| Bass, A; Bramson, C; Geoffroy, P; Levy-Cooperman, N; Malhotra, B; Matschke, K; Setnik, B; Sommerville, KW; Wolfram, G | 1 |
| Dayno, JM; Lawler, J; Lindhardt, K; Smith, MD; Webster, LR | 1 |
| BucherBartelson, B; Buttram, ME; Cicero, TJ; Dart, RC; Dasgupta, N; Ellis, MS; Gilbert, MK; Green, JL; Kurtz, SP; Parrino, MW; Rosenblum, A; Severtson, SG | 1 |
| Lexchin, J | 1 |
| Fernandes, K; Gomes, T; Juurlink, D; Mamdani, M; Martins, D; Paterson, JM; Singh, S; Spooner, L | 1 |
| Crudele, NT; Giordano, J; Kapil, RP; Randhawa, AS | 1 |
| Fleming, AB; Gudin, J; Kopecky, EA | 1 |
| Janda, KD; Kimishima, A; Wenthur, CJ; Zhou, B | 1 |
| Anastasio, NC; Comer, SD; Cunningham, KA; Fox, RG; Haney, M; Holliday, ED; Moeller, FG; Neelakantan, H; Stutz, SJ | 1 |
| Cirone, S; Edwards, C; Folk, D; Gordon, J; Kahan, M; Kanate, D; Kelly, L; Kirlew, M; Main, F; Mamakwa, S; Parsons, P; Rea, S | 1 |
| Barth, KS; Brady, KT; Guille, C; Mateus, J; McCauley, JL | 1 |
| Coe, MA; Lofwall, MR; Nuzzo, PA; Walsh, SL | 1 |
| Blondell, RD; Purdy, CH; Wisniewski, AM | 1 |
| Holtman, JR; Lofwall, MR; Nuzzo, PA; Walsh, SL | 1 |
| Campbell, ED; Cropsey, KL; Knisely, JS; Wunsch, MJ | 1 |
| Chilcoat, HD; Martins, SS; Storr, CL; Zhu, H | 1 |
| Berkelhammer, DL; Brzeski, A; Coats, BD; Crysdale, NY; Hutchinson, MR; Johnson, KW; Judd, CM; Lewis, SS; Maier, SF; Northcutt, A; Skyba, DA; Vietz, CM; Watkins, LR | 1 |
| Hamunen, K; Kalso, E; Paakkari, P | 1 |
| Parnes, LS; Rigby, MH | 1 |
| Brands, B; Catz-Biro, L; Li, S; Sproule, B | 1 |
| Chu, JA; Jaffee, WB; Woody, GE | 1 |
| Aquina, CT; Bridgeman, P; Marques-Baptista, A; Merlin, MA | 1 |
| Wilcock, A | 1 |
| Hays, L; Kirsh, KL; Passik, SD | 1 |
| Black, R; Butler, SF; Chang, A; Folensbee, L; Grimes Serrano, JM; Katz, N | 1 |
| Comer, SD; Houser, J; Kowalczyk, WJ; Sullivan, MA; Vosburg, SK | 1 |
| Moore, C; Vincent, M | 1 |
| Bigelow, GE; Harrison, JA; Lanier, RK; Strain, EC; Tompkins, DA | 1 |
| Hatton, KW; Lofwall, MR; Nuzzo, PA; Stoops, WW; Walsh, SL | 1 |
| Hermos, J | 1 |
| Pergolizzi, JV; Raffa, RB | 1 |
| Bates, C; Bishoff, J; Laciak, R; Southwick, A | 1 |
| Darke, S; Duflou, J; Torok, M | 1 |
| Cleveland, JM; Roland, CL; Setnik, B; Webster, L | 1 |
| Gutierrez, S; Zacny, JP | 1 |
| Fang, WB; Lofwall, MR; Moody, DE; Nuzzo, PA; Walsh, SL | 1 |
| Silversides, A | 1 |
| Delva, J; Momper, SL; Reed, BG | 1 |
| Alvarez-Jiménez, P; Núñez-Olarte, JM | 1 |
| Kahan, M; Mailis-Gagnon, A; Srivastava, A; Wilson, L | 1 |
| Boisvert, L; Copeland, J; Osmun, WE; Parr, J | 1 |
| Cromarty, H; Dooley, J; Hopman, W; Kelly, L; Madden, S; Minty, B; Morgan, A | 1 |
| Coalson, DW; Paice, JA; Zacny, JP | 1 |
| Lofwall, MR; Nuzzo, PA; Walsh, SL | 1 |
| Eaton, TA; Katz, NP; Osgood, ED; Trudeau, JJ | 1 |
| Eban, K | 1 |
| Boughner, E; Campbell, AT; Kwiatkowski, D; Leri, F | 1 |
| Heilig, M; Henderson, P; Lofwall, MR; Nuzzo, PA; Walsh, SL | 1 |
| Havens, JR; Jonas, AB; Leukefeld, CG; Oser, CB; Young, AM | 1 |
| Opremcak, EM | 1 |
| Lofwall, MR; Middleton, LS; Nuzzo, PA; Siegel, AJ; Walsh, SL | 1 |
| Ferrara, MM | 1 |
| Godfrey, A | 1 |
| Cicero, TJ; Ellis, MS; Surratt, HL | 1 |
| Häkkinen, M; Launiainen, T; Ojanperä, I; Vuori, E | 1 |
| Barrett, B; Moore, K; Ogle, A; Pearson, J; Young, MS | 1 |
| Fischer, B; Keates, A | 1 |
| Nelson, L; Perrone, J; Portelli, I; Wightman, R | 1 |
| Doe, J | 1 |
| Pappagallo, M; Sokolowska, M | 1 |
| Black, RA; Budman, SH; Butler, SF; Cassidy, TA; Chilcoat, H; Coplan, PM; Landau, C | 1 |
| Ruan, X | 1 |
| Bryant, CD; Cheng, R; Guido, MA; Kole, LA | 1 |
| Cepeda, MS; Fife, D; Mastrogiovanni, G; Vo, L; Yuan, Y | 1 |
| Fletcher, J; Tsuyuki, R | 1 |
| Ashworth, JB; Comer, SD; Jones, JD; Manubay, JM; Shapiro, DY; Vosburg, SK | 1 |
| Roland, CL; Setnik, B; Webster, L | 1 |
| Cone, EJ; Giordano, J; Weingarten, B | 1 |
| Gossrau, G; Heineck, R; Kaiser, U; Sabatowski, R; Scharnagel, R; Schütze, A | 1 |
| Antoine, DG; Bigelow, GE; Strain, EC; Tompkins, DA | 1 |
| Fleischman, J; Galler, D | 1 |
| Carlson, RG; Kenne, DR; Siegal, HA; Swora, MG | 1 |
| Alderson, A; Regan, JJ | 1 |
| Hoffmann, DE; Tarzian, AJ | 1 |
| Cole, B; Cutler, RB; Fishbain, DA; Lewis, J; Rosomoff, HL; Rosomoff, RS | 1 |
| Gunderson, EW | 1 |
| Katz, RT | 1 |
| Nevin, J | 1 |
| Hays, LR | 1 |
| Borrow, JA; Greenfield, SF; Hennessy, G; Potter, JS; Weiss, RD | 1 |
| Rosenberg, D | 3 |
| Burns, LH; Olmstead, MC | 1 |
| Compton, WM; Volkow, ND | 1 |
| Davis, JJ; Dillon, JD; Egan, TD; Hall, RH; Johnson, KB; Niu, SY; Pace, NL; Swenson, JD | 1 |
| Di Marino, ME; Ruediger, NK; Sees, KL; Shiffman, S; Sweeney, CT | 1 |
| Thomas, E | 1 |
| Adler, J | 1 |
| Jeske, AH | 1 |
| Cicero, TJ; Inciardi, JA; Muñoz, A | 1 |
| Glassman, P; Goodman, FD | 1 |
| Adlaf, EM; Brands, B; Paglia-Boak, A | 1 |
| Benoit, C; Bianchi, R; Budman, SH; Buse, DC; Butler, SF; Cooper, D; Fernandez, KC; Jasinski, DR; Katz, NP; Smith, DE; Wing Venuti, S | 1 |
| Naliboff, BD; Pham, Q; Wu, SM | 1 |
| Webster, LR | 1 |
| Cicero, TJ; Dart, RC; Inciardi, JA; Muñoz, A; Schnoll, S; Woody, GE | 1 |
| Cicero, TJ; Inciardi, JA; Munoz, A; Surratt, H | 1 |
| Lichtor, SA; Zacny, JP | 1 |
| Birchenough, SA; Borowitz, K; Lin, KY | 1 |
| Lavine, G | 1 |
| Dunn, KE; Heil, SH; Higgins, ST; McGee, MR; Sigmon, SC | 1 |
| Charney, DS; Kleber, HD | 1 |
| Mahowald, ML; Woods, SR; Ytterberg, SR | 1 |
| Dowling, JP; Ireton, HJ; Kerr, PG; Rhodes, HC; Segal, A; Spagnolo, DV; Thomas, GW | 1 |
| Rueter, S; Stoll, AL | 1 |
| Dahl, JL; Gilson, AM; Joranson, DE; Ryan, KM | 1 |
| Cohen, G | 1 |
| Burgess, FW | 1 |
| Goldwyn, RM | 1 |
| Abourjaily, H; Rosenberg, M; Suleman, R | 1 |
| Foley, KM; Portenoy, RK | 1 |
| Fishbain, DA; Goldberg, M; Rosomoff, H; Rosomoff, RS | 1 |
28 review(s) available for oxycodone and Addiction, Opioid
| Article | Year |
|---|---|
Sex differences in the rodent hippocampal opioid system following stress and oxycodone associated learning processes.
Topics: Analgesics, Opioid; Animals; Conditioning, Classical; Female; Hippocampus; Learning; Male; Microscopy, Electron; Neurons; Opioid Peptides; Opioid-Related Disorders; Oxycodone; Rats; Receptors, Estrogen; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sex Characteristics; Stress, Psychological | 2022 |
Prescription Opioid Use for Acute Pain and Persistent Opioid Use After Gynecologic Surgery: A Systematic Review.
Topics: Acute Pain; Aftercare; Analgesics, Opioid; Female; Gynecologic Surgical Procedures; Humans; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Patient Discharge; Practice Patterns, Physicians'; Prescriptions | 2023 |
Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments.
Topics: Analgesics, Opioid; Animals; Humans; Morphine; Opioid-Related Disorders; Oxycodone; Receptors, Opioid; Thebaine | 2023 |
The Role of Non-Pharmaceutical Fentanyl-Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses: A Commentary Review.
Topics: Analgesics, Opioid; Drug Overdose; Fentanyl; Humans; Opiate Overdose; Opioid-Related Disorders; Oxycodone; United States | 2023 |
Prescriber Education Interventions to Optimize Opioid Prescribing in Acute Care: A Systematic Review.
Topics: Analgesics, Opioid; Drug Prescriptions; Humans; Opioid-Related Disorders; Oxycodone; Pain; Practice Patterns, Physicians'; Primary Health Care | 2019 |
The Prevalence of Opioid Analgesic Use in People with Chronic Noncancer Pain: Systematic Review and Meta-Analysis of Observational Studies.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Humans; Observational Studies as Topic; Opioid-Related Disorders; Oxycodone; Prevalence | 2021 |
Oxycodone in the Opioid Epidemic: High 'Liking', 'Wanting', and Abuse Liability.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Humans; Opioid Epidemic; Opioid-Related Disorders; Oxycodone; Pain; Reward | 2021 |
Abuse-Deterrent Opioid Formulations and the Opioid Crisis: A Pharmacist's Perspective.
Topics: Analgesics, Opioid; Delayed-Action Preparations; Humans; Opioid Epidemic; Opioid-Related Disorders; Oxycodone; Pharmacists; United States | 2021 |
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
Topics: Constipation; Defecation; Female; Gastrointestinal Agents; Humans; Intestinal Diseases; Male; Nalbuphine; Naloxone; Naltrexone; Narcotic Antagonists; Neoplasms; Opioid-Related Disorders; Oxycodone; Palliative Care; Piperidines; Quaternary Ammonium Compounds; Randomized Controlled Trials as Topic; Receptors, Opioid, mu | 2018 |
The Opioid Crisis and the Orthopedic Surgeon.
Topics: Analgesics, Opioid; Arthroplasty, Replacement; Drug Prescriptions; Humans; Narcotics; Opioid-Related Disorders; Orthopedic Surgeons; Orthopedics; Oxycodone; Pain Management; Pain Measurement; Pain, Postoperative; Patient Discharge; Peripheral Nerves; Postoperative Period; United States | 2018 |
Roxybond--an abuse-deterrent formulation of short-acting oxycodone.
Topics: Abuse-Deterrent Formulations; Analgesics, Opioid; Animals; Cross-Over Studies; Humans; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone | 2018 |
Abuse-Deterrent OxyContin And Hepatitis C.
Topics: Adult; Antiviral Agents; Disease Progression; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Opioid-Related Disorders; Oxycodone; Risk Assessment; Severity of Illness Index; Substance-Related Disorders | 2019 |
Development of vaccines to treat opioid use disorders and reduce incidence of overdose.
Topics: Antigen-Antibody Complex; Blood-Brain Barrier; Drug Overdose; Fentanyl; Heroin; Humans; Opiate Substitution Treatment; Opioid Epidemic; Opioid-Related Disorders; Oxycodone; Vaccines | 2019 |
Characterization of prescription opioid abuse in the United States: focus on route of administration.
Topics: Administration, Oral; Adolescent; Adult; Analgesics; Child; Chronic Pain; Delayed-Action Preparations; Drug Overdose; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Risk Assessment; Rural Population; Sex Factors; United States | 2012 |
Sequestered naltrexone in sustained release morphine or oxycodone - a way to inhibit illicit use?
Topics: Analgesics, Opioid; Delayed-Action Preparations; Humans; Illicit Drugs; Morphine; Naltrexone; Opioid-Related Disorders; Oxycodone | 2014 |
Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation.
Topics: Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Drug Interactions; Humans; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Quality of Life | 2014 |
Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review.
Topics: Analgesics, Opioid; Canada; Humans; Methadone; Noscapine; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Risk Factors; Socioeconomic Factors; United States | 2014 |
The Misuse of Prescription Opioids: A Threat for Europe?
Topics: Analgesics, Opioid; Drug Overdose; Europe; Humans; Opioid-Related Disorders; Oxycodone; Pain; Prescription Drug Misuse; Prevalence | 2015 |
The US Congressional "Decade on Pain Control and Research" 2001-2011: A Review.
Topics: Analgesics, Opioid; Biomedical Research; Drug and Narcotic Control; Humans; Methadone; Opioid-Related Disorders; Oxycodone; Pain; Policy; Politics; Prescription Drug Diversion; Suicide, Assisted; United States | 2015 |
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use.
Topics: Adolescent; Adult; Age Distribution; Analgesics, Opioid; Child; Drug Overdose; Female; Heroin; Heroin Dependence; Humans; Male; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; United States; Young Adult | 2016 |
Gender difference in prescription opioid abuse: A focus on oxycodone and hydrocodone.
Topics: Analgesics, Opioid; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Humans; Hydrocodone; Male; Opioid-Related Disorders; Oxycodone; Sex Characteristics; Sex Factors | 2016 |
Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.
Topics: Analgesics, Opioid; Animals; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Humans; Low Back Pain; Naltrexone; Opioid-Related Disorders; Oxycodone; Practice Guidelines as Topic | 2016 |
OxyContin abuse and overdose.
Topics: Analgesics, Opioid; Delayed-Action Preparations; Diagnosis, Differential; Drug Overdose; Humans; Opioid-Related Disorders; Oxycodone | 2009 |
Opioid formulations designed to resist/deter abuse.
Topics: Analgesics, Opioid; Delayed-Action Preparations; Drug Combinations; Humans; Morphine; Naltrexone; Niacin; Opioid-Related Disorders; Oxycodone; Pain; United States | 2010 |
Likeability and abuse liability of commonly prescribed opioids.
Topics: Analgesics, Opioid; Dose-Response Relationship, Drug; Humans; Hydrocodone; Morphine; Opioid-Related Disorders; Oxycodone; Randomized Controlled Trials as Topic | 2012 |
[Chronic non-cancer-related pain. Long-term treatment with rapid-release and short-acting opioids in the context of misuse and dependency].
Topics: Abdominal Pain; Adult; Analgesics, Opioid; Chronic Pain; Diabetic Neuropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; Female; Fentanyl; Guideline Adherence; Headache Disorders; Humans; Long-Term Care; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Physician-Patient Relations; Practice Patterns, Physicians'; Prescription Drug Misuse; Risk Factors; Tilidine | 2013 |
Major increases in opioid analgesic abuse in the United States: concerns and strategies.
Topics: Analgesics, Opioid; Fentanyl; Humans; Hydrocodone; Morphine; Opioid-Related Disorders; Oxycodone; United States | 2006 |
PTI-821: sustained-release oxycodone using gel-cap technology.
Topics: Analgesics, Opioid; Capsules; Delayed-Action Preparations; Gels; Humans; Narcotics; Opioid-Related Disorders; Oxycodone; Pain; Randomized Controlled Trials as Topic | 2007 |
44 trial(s) available for oxycodone and Addiction, Opioid
| Article | Year |
|---|---|
Gabapentin and intrathecal morphine combination therapy results in decreased oral narcotic use and more consistent pain scores after posterior spinal fusion for adolescent idiopathic scoliosis.
Topics: Adolescent; Analgesia, Patient-Controlled; Analgesics, Opioid; Gabapentin; Humans; Kyphosis; Morphine; Narcotics; Nausea; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Pruritus; Retrospective Studies; Scoliosis; Spinal Fusion; Vomiting | 2021 |
Gabapentin increases the abuse liability of alcohol alone and in combination with oxycodone in participants with co-occurring opioid and alcohol use disorder.
Topics: Alcoholism; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Ethanol; Gabapentin; Humans; Opioid-Related Disorders; Oxycodone | 2022 |
Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder.
Topics: Administration, Intranasal; Adult; Benzazepines; Choice Behavior; Cross-Over Studies; Cues; Female; Heroin; Humans; Male; Opioid-Related Disorders; Oxycodone; Reinforcement, Psychology; Self Administration; Treatment Outcome | 2020 |
Acute administration of oxycodone, alcohol, and their combination on simulated driving-preliminary outcomes in healthy adults.
Topics: Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Driving Under the Influence; Drug Synergism; Ethanol; Female; Humans; Male; Models, Psychological; Opioid-Related Disorders; Oxycodone; Psychomotor Performance | 2021 |
Particle size affects pharmacokinetics of milled oxycodone hydrochloride tablet products following nasal insufflation in nondependent, recreational opioid users.
Topics: Abuse-Deterrent Formulations; Administration, Intranasal; Adolescent; Adult; Analgesics, Opioid; Area Under Curve; Cross-Over Studies; Delayed-Action Preparations; Female; Healthy Volunteers; Humans; Insufflation; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Particle Size; Tablets; Young Adult | 2021 |
Evaluation of tradipitant, a selective NK1 antagonist, on response to oxycodone in humans.
Topics: Administration, Intranasal; Adolescent; Adult; Analgesia; Analgesics, Opioid; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Neurokinin-1 Receptor Antagonists; Opioid-Related Disorders; Oxycodone; Pain Measurement; Receptors, Neurokinin-1; Reinforcement, Psychology; Self Administration; Treatment Outcome; Young Adult | 2021 |
Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans - pilot study outcomes.
Topics: Analgesics, Opioid; Humans; Opioid-Related Disorders; Oxycodone; Oxymorphone; Pilot Projects | 2021 |
Educational Video on Pain Management and Subsequent Opioid Use After Cesarean Delivery: A Randomized Controlled Trial.
Topics: Acetaminophen; Adult; Analgesics, Opioid; Cesarean Section; Female; Humans; Ibuprofen; Opioid-Related Disorders; Oxycodone; Pain Management; Pain, Postoperative; Patient Education as Topic; Postpartum Period; Pregnancy; Videotape Recording | 2021 |
Minocycline attenuates oxycodone-induced positive subjective responses in non-dependent, recreational opioid users.
Topics: Adult; Analgesia; Analgesics, Opioid; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Microglia; Middle Aged; Minocycline; New York; Opioid-Related Disorders; Oxycodone; Reward; Young Adult | 2021 |
Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with Oxycodone.
Topics: Adult; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Morphinans; Opioid-Related Disorders; Oxycodone; Young Adult | 2018 |
Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence.
Topics: Analgesics, Opioid; Craving; Heroin; Humans; Male; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Pain; Phosphodiesterase Inhibitors; Pyridines | 2017 |
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability.
Topics: Adult; Analgesia; Analgesics, Opioid; Double-Blind Method; Dronabinol; Drug Synergism; Female; Humans; Male; Marijuana Smoking; Middle Aged; Opioid-Related Disorders; Oxycodone; Pain Measurement; Young Adult | 2018 |
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Intranasal Human Abuse Potential Study of Oxycodone ARIR, a Novel, Immediate-Release, Abuse-Deterrent Formulation.
Topics: Abuse-Deterrent Formulations; Administration, Intranasal; Adult; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Tablets | 2019 |
Opioid Use following Outpatient Breast Surgery: Are Physicians Part of the Problem?
Topics: Acetaminophen; Adult; Aged; Ambulatory Surgical Procedures; Analgesics, Opioid; Drug Combinations; Drug Utilization; Female; Humans; Inappropriate Prescribing; Mammaplasty; Middle Aged; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Patient Satisfaction; Practice Patterns, Physicians'; Prospective Studies; Treatment Outcome | 2018 |
The James A. Rand Young Investigator's Award: Large Opioid Prescriptions Are Unnecessary After Total Joint Arthroplasty: A Randomized Controlled Trial.
Topics: Adult; Aged; Analgesics; Analgesics, Opioid; Arthroplasty, Replacement, Knee; Drug Prescriptions; Female; Humans; Length of Stay; Male; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Patient Reported Outcome Measures; Postoperative Period; Practice Patterns, Physicians'; Regression Analysis; Treatment Outcome | 2019 |
Pharmacokinetics, tolerability, and safety of intranasal administration of reformulated OxyContin(®) tablets compared with original OxyContin (®) tablets in healthy adults.
Topics: Administration, Intranasal; Adult; Analgesics, Opioid; Area Under Curve; Delayed-Action Preparations; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Single-Blind Method; Tablets; Young Adult | 2013 |
Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Buprenorphine; Choice Behavior; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; In Vitro Techniques; Male; Middle Aged; Morphine; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Pain Measurement; Pupil; Reward; Self Administration; Surveys and Questionnaires; Time Factors; Token Economy; Young Adult | 2013 |
Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users.
Topics: Administration, Intranasal; Adolescent; Adult; Analgesics, Opioid; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Illicit Drugs; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Young Adult | 2014 |
Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain.
Topics: Administration, Buccal; Analgesics, Opioid; Breakthrough Pain; Chronic Pain; Cross-Over Studies; Dosage Forms; Double-Blind Method; Female; Fentanyl; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Tablets | 2014 |
Abuse potential of intravenous oxycodone/naloxone solution in nondependent recreational drug users.
Topics: Adolescent; Adult; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Injections, Intravenous; Male; Middle Aged; Naloxone; Opioid-Related Disorders; Oxycodone; Reward; Young Adult | 2014 |
Patient preference with respect to QoL and reduction in opioid-induced constipation (OIC) after treatment with prolonged-release (PR) oxycodone/naloxone compared with previous analgesic therapy [PREFER study].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Constipation; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Opioid-Related Disorders; Oxycodone; Patient Preference; Quality of Life | 2014 |
Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Chemistry, Pharmaceutical; Cross-Over Studies; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Therapeutic Equivalency; Young Adult | 2015 |
The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users.
Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Pioglitazone; PPAR gamma; Single-Blind Method; Thiazolidinediones | 2016 |
Safety of oral dronabinol during opioid withdrawal in humans.
Topics: Administration, Oral; Adolescent; Adult; Analgesics, Opioid; Blood Pressure; Cannabinoid Receptor Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Heart Rate; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Pupil; Substance Withdrawal Syndrome; Tachycardia, Sinus; Treatment Outcome; Young Adult | 2015 |
A Randomized, Double-Blind, Double-Dummy Study to Evaluate the Intranasal Human Abuse Potential and Pharmacokinetics of a Novel Extended-Release Abuse-Deterrent Formulation of Oxycodone.
Topics: Administration, Intranasal; Adult; Analgesics, Opioid; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Young Adult | 2016 |
Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers.
Topics: Administration, Intranasal; Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome; Young Adult | 2016 |
Evaluation of the durability of pain relief throughout a 12 hour dosing interval of a novel, extended-release, abuse-deterrent formulation of oxycodone.
Topics: Adult; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Pain Management | 2016 |
Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans.
Topics: Administration, Oral; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Receptor, Cannabinoid, CB1; Substance Withdrawal Syndrome; Young Adult | 2016 |
Measurement of Drug Liking in Abuse Potential Studies: A Comparison of Unipolar and Bipolar Visual Analog Scales.
Topics: Adolescent; Analgesics, Opioid; Cross-Over Studies; Data Interpretation, Statistical; Delayed-Action Preparations; Double-Blind Method; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Reproducibility of Results; Research Design; Substance-Related Disorders; Visual Analog Scale; Young Adult | 2017 |
Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recreational Opioid Users.
Topics: Administration, Oral; Analgesics, Opioid; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Illicit Drugs; Male; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone | 2017 |
Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) versus Extended-Release Morphine Administered Orally in Nondependent Recreational Opioid Users.
Topics: Adult; Analgesics, Opioid; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Illicit Drugs; Male; Morphine; Opioid-Related Disorders; Oxycodone; Pennsylvania; Placebo Effect; Prevalence; Risk Factors; Substance-Related Disorders; Treatment Outcome; Young Adult | 2017 |
The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers.
Topics: Adult; Analgesics, Opioid; Dose-Response Relationship, Drug; Double-Blind Method; Euphoria; Humans; Hydrocodone; Hydromorphone; Miosis; Oculomotor Muscles; Opioid-Related Disorders; Oxycodone; Prescription Drugs; Psychomotor Performance; Pupil | 2008 |
Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Behavior, Addictive; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Naltrexone; Opioid-Related Disorders; Oxycodone; Placebos | 2010 |
Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies.
Topics: Adult; Analgesics, Opioid; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydrocodone; Injections, Intravenous; Male; Morphine; Opioid-Related Disorders; Oxycodone; Pilot Projects; Receptors, Opioid, mu | 2010 |
The abuse potential of Remoxy(®), an extended-release formulation of oxycodone, compared with immediate- and extended-release oxycodone.
Topics: Adolescent; Adult; Analgesics, Opioid; Chemistry, Pharmaceutical; Cross-Over Studies; Dosage Forms; Double-Blind Method; Fasting; Female; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Placebos; Surveys and Questionnaires; Young Adult | 2011 |
Subjective, psychomotor, and physiological effects of oxycodone alone and in combination with ethanol in healthy volunteers.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Cognition; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Ethanol; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Psychomotor Performance; Young Adult | 2011 |
Pharmacokinetics of intranasal crushed OxyContin and intravenous oxycodone in nondependent prescription opioid abusers.
Topics: Administration, Intranasal; Adult; Biological Availability; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Narcotics; Opioid-Related Disorders; Oxycodone; Tablets; Young Adult | 2012 |
Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers.
Topics: Adult; Analgesics; Analgesics, Opioid; Anticonvulsants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Interactions; Female; gamma-Aminobutyric Acid; Humans; Male; Neurotoxicity Syndromes; Opioid-Related Disorders; Oxycodone; Pregabalin; Psychomotor Performance; Respiratory Rate; Substance-Related Disorders; Toxicity Tests, Acute; Young Adult | 2012 |
Effects of cold pressor pain on the abuse liability of intranasal oxycodone in male and female prescription opioid abusers.
Topics: Administration, Intranasal; Adolescent; Adult; Blood Pressure; Cold Temperature; Double-Blind Method; Female; Heart Rate; Hostility; Humans; Hydrocortisone; Male; Middle Aged; Narcotics; Neuropsychological Tests; Opioid-Related Disorders; Oxycodone; Pain; Pain Measurement; Pressure; Pupil; Sex Characteristics; Vomiting; Young Adult | 2012 |
Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers.
Topics: Administration, Intranasal; Adult; Analgesics, Opioid; Analysis of Variance; Animals; Antiemetics; Aprepitant; Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Tolerance; Female; Humans; Male; Mice; Mice, Knockout; Morpholines; Neurokinin-1 Receptor Antagonists; Opioid-Related Disorders; Oxycodone; Placebos; Psychomotor Performance; Receptors, Neurokinin-1; Reinforcement, Psychology; Substance P; Time Factors | 2013 |
Intranasal oxycodone self-administration in non-dependent opioid abusers.
Topics: Administration, Intranasal; Double-Blind Method; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Placebos; Self Administration | 2012 |
A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers.
Topics: Adult; Analgesics, Opioid; Chemistry, Pharmaceutical; Drug Packaging; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Particle Size; Patient Satisfaction; Phenols; Prescription Drug Misuse; Prescription Fees; Tablets; Tapentadol; Treatment Outcome; Young Adult | 2013 |
Opioid abusers' ability to differentiate an opioid from placebo in laboratory challenge testing.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Cross-Over Studies; Discrimination, Psychological; Dose-Response Relationship, Drug; Double-Blind Method; Euphoria; Female; Humans; Male; Middle Aged; Narcotics; Opioid-Related Disorders; Oxycodone; Placebos; Pupil; Young Adult | 2013 |
Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers.
Topics: Administration, Oral; Adult; Affect; Analgesics, Opioid; Attention; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Mental Recall; Morphine; Motivation; Opioid-Related Disorders; Oxycodone; Pain Measurement; Psychomotor Performance; Reaction Time; Risk Factors; Surveys and Questionnaires | 2008 |
335 other study(ies) available for oxycodone and Addiction, Opioid
| Article | Year |
|---|---|
Sex and heredity are determinants of drug intake in a novel model of rat oral oxycodone self-administration.
Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Female; Genetic Predisposition to Disease; Male; Opioid-Related Disorders; Oxycodone; Rats; Rats, Inbred Dahl; Rats, Inbred F344; Rats, Inbred Lew; Rats, Wistar; Self Administration; Sex | 2021 |
Evaluation of Extended-Release Oxycodone Administered through Enteral Tubes for the Management of Pain in Patients with Head and Neck Cancer: A Case Series.
Topics: Analgesics, Opioid; Delayed-Action Preparations; Head and Neck Neoplasms; Humans; Opioid-Related Disorders; Oxycodone; Pain | 2021 |
The utility of maraviroc, an antiretroviral agent used to treat HIV, as treatment for opioid abuse? Data from MRI and behavioural testing in rats.
Topics: Analgesics, Opioid; Animals; Anti-HIV Agents; Behavior, Animal; Magnetic Resonance Imaging; Male; Maraviroc; Opioid-Related Disorders; Oxycodone; Rats | 2021 |
The release of abuse-deterrent OxyContin and adolescent heroin use.
Topics: Adolescent; Analgesics, Opioid; Heroin; Humans; Male; Opioid-Related Disorders; Oxycodone; Surveys and Questionnaires; United States | 2021 |
The effect of perioperative sustained-release opioid use on long-term opioid dispensing following total knee arthroplasty: a retrospective cohort study.
Topics: Aged; Analgesics, Opioid; Arthroplasty, Replacement, Knee; Delayed-Action Preparations; Female; Humans; Inpatients; Male; Middle Aged; New Zealand; Opioid-Related Disorders; Outpatients; Oxycodone; Pain, Postoperative; Postoperative Period; Practice Patterns, Physicians' | 2021 |
JK.
Topics: Accidents, Traffic; Acetaminophen; Analgesics, Opioid; Anxiety; Drug Combinations; Family Relations; Female; Humans; Musculoskeletal Pain; Opioid-Related Disorders; Oxycodone; Professional-Patient Relations; Self Concept | 2021 |
Pain and Opioid Consumption Following Endoscopic Sinus Surgery: A Prospective Cohort Study.
Topics: Analgesics, Opioid; Cohort Studies; Endrin; Humans; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Practice Patterns, Physicians'; Prospective Studies | 2022 |
Concentration-Response Model of Immediate Release Oxycodone Drug Liking by Different Routes of Abuse.
Topics: Analgesics, Opioid; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Humans; Opioid-Related Disorders; Oxycodone | 2022 |
A limited access oral oxycodone paradigm produces physical dependence and mesocorticolimbic region-dependent increases in DeltaFosB expression without preference.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Disease Models, Animal; Locomotion; Mice; Naloxone; Narcotic Antagonists; Nociception; Nucleus Accumbens; Opioid-Related Disorders; Oxycodone; Proto-Oncogene Proteins c-fos; Substance Withdrawal Syndrome | 2022 |
Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report.
Topics: Analgesics, Opioid; Anemia, Sickle Cell; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Young Adult | 2022 |
Managing the opioid crisis in North America and beyond.
Topics: Analgesics, Opioid; COVID-19; Humans; North America; Opioid Epidemic; Opioid-Related Disorders; Oxycodone; Pain; Public Health | 2022 |
Enhanced Recovery after Surgery Protocol to Improve Racial and Ethnic Disparities in Postcesarean Pain Management.
Topics: Acetaminophen; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents; Celecoxib; Endrin; Enhanced Recovery After Surgery; Female; Humans; Opioid-Related Disorders; Oxycodone; Pain Management; Pain, Postoperative; Pregnancy; Retrospective Studies | 2022 |
Oxycodone-related deaths in Sweden 2006-2018.
Topics: Aged; Analgesics, Opioid; Benzodiazepines; Humans; Opioid-Related Disorders; Oxycodone; Pain; Sweden | 2022 |
An Evaluation of the Effect of the OxyContin Reformulation on Unintentional Fatal and Nonfatal Overdose.
Topics: Analgesics, Opioid; Drug Overdose; Humans; Morphine; Opioid-Related Disorders; Oxycodone; United States | 2022 |
Incarceration exposure and prescription opioid use during pregnancy.
Topics: Analgesics, Opioid; Female; Humans; Opioid-Related Disorders; Oxycodone; Pregnancy; Prescriptions; Tramadol | 2022 |
Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia.
Topics: Aftercare; Analgesics, Opioid; Australia; Humans; Observational Studies as Topic; Opioid-Related Disorders; Oxycodone; Patient Discharge; Retrospective Studies; Tapentadol | 2022 |
Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario.
Topics: Analgesics, Opioid; Drug Prescriptions; Humans; Morphine; Ontario; Opioid-Related Disorders; Oxycodone | 2022 |
Opioid Antagonist Nanodrugs Successfully Attenuate the Severity of Ischemic Stroke.
Topics: Analgesics, Opioid; Animals; Ischemic Stroke; Mice; Morphine; Naloxone; Naltrexone; Nanoparticles; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Stroke; Tight Junction Proteins | 2022 |
Opioid Consumption After Urogynecologic Surgery: A Prospective Multicenter Observational Study Using a Text-Messaging Survey Tool.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Cohort Studies; Female; Humans; Ibuprofen; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Prospective Studies; Text Messaging | 2022 |
Reduced Opioid Use and Prescribing in a Same Day Discharge Pilot Enhanced Recovery Program for Elective Minimally Invasive Colorectal Surgical Procedures During the COVID-19 Pandemic.
Topics: Analgesics, Opioid; Colorectal Neoplasms; COVID-19; Elective Surgical Procedures; Humans; Minimally Invasive Surgical Procedures; Narcotics; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Pandemics; Patient Discharge; Retrospective Studies | 2022 |
A Prospective Analysis of Opioid Use Following Outpatient Pediatric Urologic Surgery.
Topics: Acetaminophen; Analgesics, Opioid; Child; Child, Preschool; Female; Humans; Ibuprofen; Male; Opioid-Related Disorders; Outpatients; Oxycodone; Pain, Postoperative; Practice Patterns, Physicians' | 2022 |
Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas.
Topics: Adult; Analgesics, Opioid; Arkansas; Drug Overdose; Humans; Hydrocodone; Opioid-Related Disorders; Oxycodone; Retrospective Studies; Tramadol | 2022 |
Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada: An interrupted time series study.
Topics: Analgesics, Opioid; Canada; Cohort Studies; Crack Cocaine; Heroin; Humans; Interrupted Time Series Analysis; Methamphetamine; Opioid-Related Disorders; Oxycodone; Powders; Prospective Studies | 2022 |
Postoperative Utilization of Opioids After Midurethral Sling Surgery: A Prospective Clinical Practice Study.
Topics: Aftercare; Analgesics, Opioid; Female; Humans; Narcotics; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Patient Discharge; Prospective Studies; Suburethral Slings | 2022 |
Perinatal oxycodone exposure causes long-term sex-dependent changes in weight trajectory and sensory processing in adult mice.
Topics: Analgesics, Opioid; Animals; Body-Weight Trajectory; Female; Humans; Infant, Newborn; Male; Mice; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Oxycodone; Perception; Pregnancy; Substance Withdrawal Syndrome | 2022 |
Chronicity of repeated blast traumatic brain injury associated increase in oxycodone seeking in rats.
Topics: Animals; Brain Injuries, Traumatic; Drug-Seeking Behavior; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Self Administration | 2023 |
The opioid epidemic: A worldwide exploratory study using the WHO pharmacovigilance database.
Topics: Analgesics, Opioid; Bayes Theorem; Codeine; Fentanyl; Humans; Morphine; Opioid Epidemic; Opioid-Related Disorders; Oxycodone; Pharmacovigilance; Tramadol; World Health Organization | 2023 |
Associations between postpartum pain type, pain intensity and opioid use in patients with and without opioid use disorder: a cross-sectional study.
Topics: Analgesics, Opioid; Cross-Sectional Studies; Female; Humans; Opioid-Related Disorders; Oxycodone; Pain; Pain Measurement; Postpartum Period; Pregnancy | 2023 |
A preliminary study of hydrocodone and hydromorphone to oxycodone ratios for distinguishing impurities from independent opioid use.
Topics: Analgesics, Opioid; Chromatography, Liquid; Humans; Hydrocodone; Hydromorphone; Opioid-Related Disorders; Oxycodone; Oxymorphone; Tandem Mass Spectrometry | 2023 |
Effect of discharge opioid on persistent postoperative opioid use: a retrospective cohort study comparing tapentadol with oxycodone.
Topics: Analgesics, Opioid; Humans; Opioid-Related Disorders; Oxycodone; Patient Discharge; Phenols; Retrospective Studies; Tapentadol | 2023 |
Oral oxycodone self-administration leads to features of opioid misuse in male and female mice.
Topics: Analgesics, Opioid; Animals; Female; Fentanyl; Male; Mice; Opioid-Related Disorders; Oxycodone; Reinforcement, Psychology | 2023 |
Endomorphin analog ZH853 shows low reward, tolerance, and affective-motivational signs of withdrawal, while inhibiting opioid withdrawal and seeking.
Topics: Analgesics, Opioid; Animals; Female; Humans; Male; Mice; Morphine; Narcotics; Opioid-Related Disorders; Oxycodone; Rats; Reward; Substance Withdrawal Syndrome | 2023 |
Selective M
Topics: Analgesics, Opioid; Animals; Male; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Self Administration; Sucrose | 2023 |
Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients.
Topics: Analgesics, Opioid; Chronic Pain; Humans; Hydrocodone; Opioid-Related Disorders; Oxycodone; Retrospective Studies; Tramadol | 2023 |
Evaluating the effectiveness of reformulated extended-release oxycodone with abuse-deterrent properties on reducing non-oral abuse among individuals assessed for substance abuse treatment with the Addiction Severity Index-Multimedia Version (ASI-MV).
Topics: Adult; Analgesics, Opioid; Delayed-Action Preparations; Humans; Multimedia; Opioid-Related Disorders; Oxycodone; Tablets | 2023 |
A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population.
Topics: Abuse-Deterrent Formulations; Analgesics, Opioid; Cross-Sectional Studies; Delayed-Action Preparations; Humans; Opioid-Related Disorders; Oxycodone; Oxymorphone | 2023 |
Medical Opioid Disposal in Fukuoka and Kumamoto Cities.
Topics: Analgesics, Opioid; Cities; Fentanyl; Humans; Opioid-Related Disorders; Oxycodone | 2023 |
What Changes Have Occurred in Opioid Prescriptions and the Prescribers of Opioids Before TKA and THA? A Large National Registry Study.
Topics: Aged; Analgesics, Opioid; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Female; Humans; Male; Opioid-Related Disorders; Osteoarthritis; Oxycodone; Pain, Postoperative; Practice Patterns, Physicians'; Prescriptions; Registries; Retrospective Studies | 2023 |
Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys.
Topics: Analgesics, Opioid; Animals; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Macaca fascicularis; Male; Naltrexone; Opioid-Related Disorders; Oxycodone; Receptors, Dopamine D3; Self Administration | 2023 |
Ketogenic diet enhances the effects of oxycodone in mice.
Topics: Alcoholism; Analgesics, Opioid; Animals; Diet, Ketogenic; Female; Male; Mice; Opioid-Related Disorders; Oxycodone; Pain; Psychomotor Agitation | 2023 |
Strain and sex-related behavioral variability of oxycodone dependence in rats.
Topics: Analgesics, Opioid; Animals; Female; Male; Opioid-Related Disorders; Oxycodone; Rats; Rats, Inbred ACI; Rats, Inbred F344; Rats, Inbred WKY; Self Administration | 2023 |
Opioid analgesic effects on subjective well-being in the operating theatre.
Topics: Analgesics, Opioid; Bayes Theorem; Humans; Opioid-Related Disorders; Oxycodone; Remifentanil | 2023 |
Early OxyContin Marketing Linked To Long-Term Spread Of Infectious Diseases Associated With Injection Drug Use.
Topics: Analgesics, Opioid; Communicable Diseases; Drug Overdose; Humans; Marketing; Opioid-Related Disorders; Oxycodone; United States | 2023 |
Prescription of oxycodone versus codeine after childbirth and risk of persistent opioid use: a population-based cohort study.
Topics: Analgesics, Opioid; Codeine; Cohort Studies; Drug Prescriptions; Female; Humans; Infant, Newborn; Opioid-Related Disorders; Oxycodone; Pregnancy; Retrospective Studies | 2023 |
[Opioid dependent patient with two prescribers].
Topics: Analgesics, Opioid; Fentanyl; General Practitioners; Humans; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians' | 2023 |
Differences in severity of poison centers exposures involving XTAMPZA
Topics: Analgesics, Opioid; Delayed-Action Preparations; Humans; Morphine; Opioid-Related Disorders; Oxycodone | 2023 |
Dietary Supplementation with Omega-3 Polyunsaturated Fatty Acids Reduces Opioid-Seeking Behaviors and Alters the Gut Microbiome.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Brain; Dietary Supplements; Disease Models, Animal; Drug-Seeking Behavior; Fatty Acids, Omega-3; Gastrointestinal Microbiome; Male; Mice, Inbred C57BL; Microglia; Opioid-Related Disorders; Oxycodone; Recurrence; Substance Withdrawal Syndrome | 2019 |
Case 26-2019: A 27-Year-Old Woman with Opioid Use Disorder and Suicidal Ideation.
Topics: Adult; Diagnosis, Differential; Diagnosis, Dual (Psychiatry); Elbow Injuries; Elbow Joint; Female; Heroin Dependence; Humans; Ill-Housed Persons; Joint Dislocations; Malingering; Opioid-Related Disorders; Oxycodone; Radiography; Suicidal Ideation; Suicide, Attempted; Tomography, X-Ray Computed | 2019 |
Oral prescription opioid-seeking behavior in male and female mice.
Topics: Administration, Oral; Animals; Behavior, Animal; Cues; Drug-Seeking Behavior; Female; Male; Mice; Mice, Inbred C57BL; Opioid-Related Disorders; Oxycodone; Self Administration; Sex Factors; Substance Abuse, Oral | 2020 |
Who is HOT and who is LOT? Detailed characterization of prescription opioid-induced changes in behavior between 129P3/J and 129S1/SvlmJ mouse substrains.
Topics: Analgesics, Opioid; Animals; Anxiety; Choice Behavior; Conditioning, Operant; Female; Fentanyl; Genotype; Locomotion; Male; Mice; Mice, Inbred C57BL; Motivation; Opioid-Related Disorders; Oxycodone; Spatial Behavior | 2020 |
Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone.
Topics: Adult; Catechol O-Methyltransferase; Dopamine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Opioid Peptides; Opioid-Related Disorders; Oxycodone; Polymorphism, Genetic; Young Adult | 2019 |
Reversal of oxycodone conditioned place preference by oxytocin: Promoting global DNA methylation in the hippocampus.
Topics: Animals; Conditioning, Psychological; DNA Methylation; Epigenesis, Genetic; Extinction, Psychological; Hippocampus; Learning; Male; Memory; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Oxytocin; Rats; Rats, Sprague-Dawley | 2019 |
Emerging Toxidromes: A 25-Year-Old Woman with Syncope and ECG Changes.
Topics: Adult; Electrocardiography; Female; Humans; Loperamide; Opioid-Related Disorders; Oxycodone; Self Medication; Substance Withdrawal Syndrome; Syncope | 2019 |
Examining opioid-involved overdose mortality trends prior to fentanyl: New York City, 2000-2015.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cross-Sectional Studies; Death Certificates; Drug Overdose; Female; Fentanyl; Heroin; Humans; Illicit Drugs; Male; Middle Aged; Mortality; New York City; Opioid-Related Disorders; Oxycodone; Young Adult | 2019 |
Long-term use of hydrocodone vs. oxycodone in primary care.
Topics: Adult; Aged; Analgesics, Opioid; Cohort Studies; Drug Prescriptions; Female; Humans; Hydrocodone; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Primary Health Care; Retrospective Studies; Time Factors | 2019 |
Adverse health effects of abuse-deterrent opioids: Evidence from the reformulation of OxyContin.
Topics: Analgesics, Opioid; Drug Administration Routes; Drug Overdose; Hepatitis A; Hepatitis B; Hepatitis C; Heroin; HIV Infections; Humans; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; Substance Abuse, Intravenous; Technology, Pharmaceutical; United States | 2019 |
Murine model of OPRM1 A118G alters oxycodone self-administration and locomotor activation, but not conditioned place preference.
Topics: Analgesics, Opioid; Animals; Conditioning, Classical; Dose-Response Relationship, Drug; Female; Locomotion; Male; Mice; Mice, Transgenic; Opioid-Related Disorders; Oxycodone; Receptors, Opioid, mu; Self Administration | 2020 |
Discrimination learning in oxycodone-treated nonhuman primates.
Topics: Analgesics, Opioid; Animals; Discrimination Learning; Dose-Response Relationship, Drug; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Primates; Saimiri; Self Administration; Substance Withdrawal Syndrome | 2020 |
Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats.
Topics: Analgesics, Opioid; Animals; Benzoxazoles; Drug-Seeking Behavior; Isoquinolines; Male; Naphthyridines; Opioid-Related Disorders; Orexin Receptors; Orexins; Oxycodone; Prescription Drug Misuse; Pyridines; Rats; Rats, Wistar; Self Administration; Urea | 2020 |
Industry influence and Health Canada's responsibility: lessons from the opioid epidemic in Canada.
Topics: Analgesics, Opioid; Canada; Drug Industry; Drug Labeling; Humans; Narcotics; Opioid Epidemic; Opioid-Related Disorders; Oxycodone | 2020 |
Nociceptin attenuates the escalation of oxycodone self-administration by normalizing CeA-GABA transmission in highly addicted rats.
Topics: Amygdala; Animals; gamma-Aminobutyric Acid; Humans; Male; Nociceptin; Opioid Peptides; Opioid-Related Disorders; Oxycodone; Rats; Self Administration | 2020 |
Effects of oxycodone and diazepam alone and in combination on operant nociception.
Topics: Analgesics; Animals; Conditioning, Operant; Diazepam; Drug Therapy, Combination; Male; Models, Animal; Nociception; Opioid-Related Disorders; Oxycodone; Pain; Pain Measurement; Saimiri | 2020 |
Female and male rats readily consume and prefer oxycodone to water in a chronic, continuous access, two-bottle oral voluntary paradigm.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Choice Behavior; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Male; Opioid-Related Disorders; Oxycodone; Rats; Rats, Long-Evans; Self Administration; Sex Characteristics; Substance Withdrawal Syndrome; Water | 2020 |
Managing opioid consumption after caesarean delivery: a quality improvement initiative.
Topics: Adult; Analgesics, Opioid; Cesarean Section; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Pain Management; Pain, Postoperative; Pregnancy | 2020 |
Prescription Opioid Prescribing in Western Europe and the United States.
Topics: Acute Pain; Analgesics, Opioid; Chronic Pain; Cross-Cultural Comparison; Drug Overdose; Drug Prescriptions; Europe; Humans; Opioid-Related Disorders; Oxycodone; Pain Management; Practice Patterns, Physicians'; Rhode Island | 2020 |
Lipid microsphere bound oxycodone for pain management in patients receiving radiotherapy for head and neck cancer.
Topics: Analgesia; Analgesics, Opioid; Deglutition Disorders; Delayed-Action Preparations; Female; Gastrostomy; Head and Neck Neoplasms; Humans; Male; Microspheres; Middle Aged; Morphine; Mucositis; Opioid-Related Disorders; Oxycodone; Pain; Pain Management; Prospective Studies; Quality of Life | 2021 |
How I treat pain in hematologic malignancies safely with opioid therapy.
Topics: Abdominal Pain; Adult; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Back Pain; Chronic Pain; Combined Modality Therapy; Disease Susceptibility; Drug Monitoring; Hematologic Neoplasms; Hostility; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Multiple Myeloma; Opioid-Related Disorders; Oxycodone; Pain Management; Patient Education as Topic; Phantom Limb; Physical Therapy Modalities; Risk Assessment; Stress Disorders, Post-Traumatic; Substance-Related Disorders; Thrombocythemia, Essential; Yoga | 2020 |
A Multimodal Protocol to Diminish Pain Following Common Orthopedic Sports Procedures: Can We Eliminate Postoperative Opioids?
Topics: Adolescent; Adult; Analgesia; Analgesics, Opioid; Anterior Cruciate Ligament; Anxiety; Arthroscopy; Athletic Injuries; Depression; Female; Humans; Male; Meniscectomy; Middle Aged; Morphine; Opioid-Related Disorders; Orthopedics; Oxycodone; Pain Management; Pain, Postoperative; Patient Satisfaction; Postoperative Period; Prospective Studies; Rotator Cuff; Shoulder Joint; Visual Analog Scale; Young Adult | 2020 |
Polymer-mediated delivery of vaccines to treat opioid use disorders and to reduce opioid-induced toxicity.
Topics: Analgesics, Opioid; Animals; Mice; Opioid-Related Disorders; Oxycodone; Polymers; Rats; Vaccines | 2020 |
Accidental Overdose Deaths in Oklahoma, 2002-2017: Opioid and Methamphetamine Trends.
Topics: Adult; Analgesics, Opioid; Drug Overdose; Female; Heroin; Humans; Male; Methamphetamine; Oklahoma; Opioid-Related Disorders; Oxycodone | 2020 |
The antagonistic activity profile of naloxone in μ-opioid receptor agonist-induced psychological dependence.
Topics: Analgesics, Opioid; Animals; Male; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2020 |
Reduction of Drug-Drug Interaction Risk; CDC Guidelines Influence on Opiate Benzodiazepine Prescribing.
Topics: Benzodiazepines; Centers for Disease Control and Prevention, U.S.; Drug Interactions; Drug Therapy, Combination; Guideline Adherence; Humans; Hydrocodone; Morphine; Opiate Alkaloids; Opioid-Related Disorders; Oxycodone; Pain; Pharmaceutical Preparations; United States | 2020 |
Development of Persistent Opioid Use After Cardiac Surgery.
Topics: Cardiac Surgical Procedures; Female; Humans; Male; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Retrospective Studies; Risk Factors; Time Factors | 2020 |
Combining a Candidate Vaccine for Opioid Use Disorders with Extended-Release Naltrexone Increases Protection against Oxycodone-Induced Behavioral Effects and Toxicity.
Topics: Analgesics, Opioid; Animals; Brain; Delayed-Action Preparations; Hemocyanins; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Rats; Vaccines | 2020 |
Reformulation of oxycodone 80 mg to prevent misuse: A cohort study assessing the impact of a supply-side intervention.
Topics: Analgesics, Opioid; Cohort Studies; Delayed-Action Preparations; Humans; New York City; Opioid-Related Disorders; Oxycodone; Retrospective Studies | 2020 |
The kappa-opioid receptor agonist, nalfurafine, blocks acquisition of oxycodone self-administration and oxycodone's conditioned rewarding effects in male rats.
Topics: Analgesics, Opioid; Animals; Conditioning, Classical; Dose-Response Relationship, Drug; Male; Morphinans; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, kappa; Reinforcement, Psychology; Reward; Self Administration; Spiro Compounds; Substance-Related Disorders | 2020 |
Regulating Opioid Supply Through Insurance Coverage.
Topics: Analgesics, Opioid; Canada; Humans; Insurance Coverage; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians' | 2020 |
Characterization of the intergenerational impact of in utero and postnatal oxycodone exposure.
Topics: Analgesics, Opioid; Animals; Anxiety; Female; Opioid-Related Disorders; Oxycodone; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Sequence Analysis, RNA | 2020 |
Nature of adverse events with opioids in hospitalised patients: a post-hoc analysis of three patient record review studies.
Topics: Aged; Analgesics, Opioid; Drug-Related Side Effects and Adverse Reactions; Humans; Opioid-Related Disorders; Oxycodone; Retrospective Studies | 2020 |
Evolution of doctor shopping for oxycodone in the 67 million inhabitants in France as a proxy for potential misuse or abuse.
Topics: Adult; Analgesics, Opioid; Cross-Sectional Studies; Databases, Factual; France; Humans; Male; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians' | 2021 |
Overprescription of Opioids Following Outpatient Anorectal Surgery: A Single-Institution Study.
Topics: Analgesics, Opioid; Digestive System Surgical Procedures; Female; Hemorrhoidectomy; Humans; Male; Middle Aged; Opioid-Related Disorders; Outcome Assessment, Health Care; Oxycodone; Pain, Postoperative; Patient Discharge; Patient Reported Outcome Measures; Practice Patterns, Physicians'; Rectal Diseases; Retrospective Studies; Risk Assessment | 2020 |
Chronic opioid exposure differentially modulates oxycodone self-administration in male and female rats.
Topics: Animals; Female; Male; Morphine; Narcotics; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome | 2021 |
Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER.
Topics: Analgesics, Opioid; Delayed-Action Preparations; Humans; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; Substance Abuse Treatment Centers | 2020 |
Tramadol non-medical use in Four European countries: A comparative analysis.
Topics: Adult; Analgesics, Opioid; Codeine; Cross-Sectional Studies; Europe; Female; Germany; Humans; Italy; Male; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; Prescription Drugs; Spain; Tramadol; United Kingdom; Young Adult | 2020 |
Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines.
Topics: Adult; Analgesics, Opioid; Centers for Disease Control and Prevention, U.S.; Codeine; Cross-Sectional Studies; Drug Prescriptions; Female; Guideline Adherence; Guidelines as Topic; Humans; Hydrocodone; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Tramadol; United States | 2020 |
Relative addictive potential of opioid analgesic agents.
Topics: Analgesics, Opioid; Drug Prescriptions; Fentanyl; Humans; Opioid-Related Disorders; Oxycodone; Pharmacogenetics | 2021 |
Adolescent oxycodone exposure inhibits withdrawal-induced expression of genes associated with the dopamine transmission.
Topics: Analgesics, Opioid; Animals; Dopamine; Epigenesis, Genetic; Gene Expression; Male; Mice; Morphine; Opioid-Related Disorders; Oxycodone; Reward; Self Administration; Ventral Tegmental Area | 2021 |
The Impact of Food on Bioavailability of Oxycodone Myristate: A Case Report.
Topics: Analgesics, Opioid; Biological Availability; Delayed-Action Preparations; Female; Humans; Myristates; Opioid-Related Disorders; Oxycodone | 2021 |
Abuse-deterrent extended-release oxycodone and risk of opioid-related harm.
Topics: Analgesics, Opioid; Child; Cohort Studies; Delayed-Action Preparations; Electronic Health Records; Female; Humans; Male; Opioid-Related Disorders; Oxycodone | 2021 |
An evaluation of online discussion relating to nonmedical use of prescription opioids within the UK.
Topics: Analgesics, Opioid; Humans; Hydrocodone; Opioid-Related Disorders; Oxycodone; Prescriptions; United Kingdom | 2021 |
The Purdue Pharma Opioid Settlement - Accountability, or Just the Cost of Doing Business?
Topics: Analgesics, Opioid; Bioethical Issues; Drug Industry; Humans; Marketing; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Social Justice; Social Responsibility; United States | 2021 |
Is the rise in illicit opioids affecting labor supply and disability claiming rates?
Topics: Analgesics, Opioid; Heroin; Humans; Opioid-Related Disorders; Oxycodone; United States; Workforce | 2021 |
Measuring prescription opioid misuse and its consequences.
Topics: Analgesics, Opioid; Humans; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Prescription Drug Misuse | 2021 |
Opioid use after cesarean: a cohort study comparing combined versus separate oxycodone and acetaminophen regimens.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Cohort Studies; Female; Humans; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Pregnancy; Retrospective Studies | 2022 |
Maternal continuous oral oxycodone self-administration alters pup affective/social communication but not spatial learning or sensory-motor function.
Topics: Administration, Oral; Affect; Analgesics, Opioid; Animals; Animals, Newborn; Behavior, Animal; Communication; Disease Models, Animal; Female; Male; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Oxycodone; Pregnancy; Pregnancy Complications; Rats; Self Administration; Spatial Learning; Substance Withdrawal Syndrome | 2021 |
Leftover Opioid Analgesics and Disposal Following Ambulatory Pediatric Surgeries in the Context of a Restrictive Opioid-Prescribing Policy.
Topics: Acute Pain; Analgesics, Opioid; Child; Child, Preschool; Drug and Narcotic Control; Female; Humans; Infant; Infant, Newborn; Male; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Parents; Patient Safety; Pediatrics; Practice Patterns, Physicians'; Retrospective Studies; Risk; Tennessee | 2022 |
High fructose corn syrup alters behavioural and neurobiological responses to oxycodone in rats.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Conditioning, Psychological; Diet; Dopamine; High Fructose Corn Syrup; Locomotion; Male; Nucleus Accumbens; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Reward | 2021 |
Validation and characterization of oxycodone physical dependence in C57BL/6J mice.
Topics: Analgesics; Analgesics, Opioid; Animals; Behavior, Animal; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice, Inbred C57BL; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Substance Withdrawal Syndrome | 2021 |
Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder.
Topics: Animals; Antibodies; Brain; Fentanyl; Male; Opioid-Related Disorders; Oxycodone; Rats; Vaccination; Vaccines | 2021 |
Commentary on Paljarvi et al: Can harder-to-crush oxycodone prevent overdose?
Topics: Drug Overdose; Humans; Opioid-Related Disorders; Oxycodone | 2021 |
Contribution of Antibody-Mediated Effector Functions to the Mechanism of Efficacy of Vaccines for Opioid Use Disorders.
Topics: Animals; Antibodies, Monoclonal; Mice; Opioid-Related Disorders; Oxycodone; Vaccines | 2021 |
Physician Dispensing of Oxycodone and Other Commonly Used Opioids, 2000-2015, United States.
Topics: Analgesics, Opioid; Controlled Substances; Drug Overdose; Drug Prescriptions; Humans; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Prescription Drug Misuse; United States | 2018 |
Patients at Risk: Large Opioid Prescriptions After Total Knee Arthroplasty.
Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics, Opioid; Arthroplasty, Replacement, Knee; Drug Combinations; Drug Prescriptions; Female; Follow-Up Studies; Humans; Hydrocodone; Hydromorphone; Knee Joint; Male; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Patient Discharge; Reoperation; Retrospective Studies | 2017 |
Potential drug interaction with opioid agonist in the setting of chronic low-dose opioid antagonist use.
Topics: Aged; Analgesics, Opioid; Disabled Persons; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Multiple Sclerosis; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Pressure Ulcer; Treatment Outcome | 2017 |
Impact of pharmacists assisting with prescribing and undertaking medication review on oxycodone prescribing and supply for patients discharged from surgical wards.
Topics: Adult; Aged; Analgesics, Opioid; Drug Utilization Review; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Patient Discharge; Pharmacists; Pharmacy Service, Hospital; Practice Patterns, Physicians'; Prescription Drug Overuse; Professional Role; Prospective Studies; Retrospective Studies | 2017 |
Variability in prescription opioid intake and reinforcement amongst 129 substrains.
Topics: Analgesics, Opioid; Animals; Fentanyl; Genetic Variation; Heroin; Male; Mice; Opioid-Related Disorders; Oxycodone; Reinforcement, Psychology; Substance Withdrawal Syndrome | 2017 |
Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats.
Topics: Analgesics; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Male; Models, Animal; Morphinans; Nociception; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Reinforcement, Psychology; Respiration; Self Administration; Spiro Compounds | 2017 |
Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: findings from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System Web Monitoring Program.
Topics: Abuse-Deterrent Formulations; Analgesics, Opioid; Drug Compounding; Humans; Internet; Opioid-Related Disorders; Oxycodone; Prescription Drug Monitoring Programs; Public Health Surveillance | 2017 |
'Delisting' OxyContin® to reduce prescription opioid-related harms in Ontario (Canada)-gauging effects 5 years later.
Topics: Analgesics, Opioid; Humans; Ontario; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Prescription Drug Diversion | 2017 |
Thrombotic microangiopathy associated with intravenous injection of extended-release oxycodone.
Topics: Adult; Analgesics, Opioid; Antibodies, Monoclonal, Humanized; Complement Inactivating Agents; Delayed-Action Preparations; Humans; Injections, Intravenous; Male; Opioid-Related Disorders; Oxycodone; Oxymorphone; Renal Insufficiency; Substance Abuse, Intravenous; Thrombotic Microangiopathies | 2017 |
Trends in heroin and pharmaceutical opioid overdose deaths in Australia.
Topics: Analgesics, Opioid; Australia; Drug Overdose; Fentanyl; Heroin; Humans; Morphine; Opioid-Related Disorders; Oxycodone; Pharmaceutical Preparations; Tramadol | 2017 |
Reversal of oxycodone and hydrocodone tolerance by diazepam.
Topics: Analgesics, Opioid; Animals; Diazepam; Dose-Response Relationship, Drug; Drug Tolerance; Hydrocodone; Male; Mice; Opioid-Related Disorders; Oxycodone | 2017 |
Important statistical considerations in the evaluation of post-market studies to assess whether opioids with abuse-deterrent properties result in reduced abuse in the community.
Topics: Analgesics, Opioid; Data Interpretation, Statistical; Delayed-Action Preparations; Drug Compounding; Humans; Opioid-Related Disorders; Oxycodone; Pain; Prescription Drug Misuse; Prescriptions; Product Surveillance, Postmarketing | 2018 |
The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats.
Topics: Animals; Dose-Response Relationship, Drug; Drug Partial Agonism; Drug-Seeking Behavior; Extinction, Psychological; Heroin; Indoles; Male; Naphthalenes; Narcotics; Opioid-Related Disorders; Oxycodone; Piperazines; Quinolines; Rats, Long-Evans; Receptors, Dopamine D3; Self Administration | 2017 |
In Vitro Drug Release After Crushing: Evaluation of Xtampza
Topics: Administration, Oral; Analgesics, Opioid; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Liberation; Humans; Opioid-Related Disorders; Oxycodone; Tablets | 2017 |
ADF: Abuse-Deterrent Formulation or Another Disillusioned Formulation?
Topics: Abuse-Deterrent Formulations; Analgesics, Opioid; Humans; Opioid-Related Disorders; Oxycodone; United States; United States Food and Drug Administration | 2018 |
Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.
Topics: Animals; Antidotes; Male; Mice; Naloxone; Opioid-Related Disorders; Oxycodone; Rats; Vaccines | 2017 |
Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System.
Topics: Analgesics, Opioid; Chronic Pain; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Retrospective Studies; Substance-Related Disorders; Tapentadol | 2018 |
The impact of OxyContin reformulation at the Sydney Medically Supervised Injecting Centre: Pros and cons.
Topics: Adult; Analgesics, Opioid; Drug Compounding; Drug Overdose; Female; Heroin Dependence; Humans; Male; Morphine Dependence; Needle-Exchange Programs; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; Substance Abuse Treatment Centers; Treatment Outcome; Victoria | 2018 |
Opioid drug poisonings in Ohio adolescents and young adults, 2002-2014.
Topics: Adolescent; Adolescent Behavior; Adult; Age Factors; Analgesics, Opioid; Child; Drug Overdose; Female; Forecasting; Humans; Male; Ohio; Opioid-Related Disorders; Oxycodone; Poison Control Centers; Sex Factors; Tramadol; Young Adult | 2018 |
The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study.
Topics: Analgesics, Opioid; Australia; Chemistry, Pharmaceutical; Drug Administration Routes; Drug Overdose; Humans; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; Prospective Studies; Time Factors | 2018 |
Trends and uptake of new formulations of controlled-release oxycodone in Canada.
Topics: Analgesics, Opioid; Canada; Chronic Pain; Cross-Sectional Studies; Delayed-Action Preparations; Drug Prescriptions; Drugs, Generic; Humans; Opioid-Related Disorders; Oxycodone; Pharmacies; Practice Patterns, Physicians' | 2018 |
Opioids for Acute Pain: Proceed with Caution.
Topics: Acetaminophen; Acute Pain; Adult; Analgesics, Opioid; Chronic Pain; Drug Combinations; Female; Fractures, Bone; Humans; Opioid-Related Disorders; Oxycodone; United States | 2018 |
Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations.
Topics: Analgesics, Opioid; Chronic Pain; Databases, Factual; Dose-Response Relationship, Drug; Drug Combinations; Drug Prescriptions; Drug Utilization; Fentanyl; Humans; Israel; Opioid-Related Disorders; Oxycodone; Pharmacoepidemiology; Practice Patterns, Physicians' | 2018 |
Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in Rats.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Drug Administration Routes; Heroin; Male; Opioid-Related Disorders; Oxycodone; Rats; Vaccines | 2018 |
Development of a Quantitative LC-MS-MS Assay for Codeine, Morphine, 6-Acetylmorphine, Hydrocodone, Hydromorphone, Oxycodone and Oxymorphone in Neat Oral Fluid.
Topics: Analgesics, Opioid; Calibration; Chromatography, Liquid; Codeine; Humans; Hydrocodone; Hydromorphone; Morphine; Morphine Derivatives; Opioid-Related Disorders; Oxycodone; Oxymorphone; Predictive Value of Tests; Reference Standards; Reproducibility of Results; Saliva; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Tandem Mass Spectrometry | 2018 |
Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Australia; Delayed-Action Preparations; Drug Compounding; Female; Humans; Interrupted Time Series Analysis; Logistic Models; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians' | 2018 |
Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose.
Topics: Animals; Antibodies, Monoclonal; Drug Overdose; Immunization; Interleukin-4; Male; Mice; Opioid-Related Disorders; Oxycodone; Signal Transduction; Vaccines | 2018 |
Doctor shopping of opioid analgesics relative to benzodiazepines: A pharmacoepidemiological study among 11.7 million inhabitants in the French countries.
Topics: Adult; Analgesics, Opioid; Benzodiazepines; Databases, Factual; Drug Prescriptions; Fentanyl; Humans; Male; Morphine; Opioid-Related Disorders; Oxycodone; Pain; Pharmacoepidemiology; Practice Patterns, Physicians'; Prescription Drug Misuse | 2018 |
Opioid Deaths in Milwaukee County, Wisconsin 2013-2017: The Primacy of Heroin and Fentanyl.
Topics: Analgesics, Opioid; Buprenorphine; Coroners and Medical Examiners; Fentanyl; Heroin; Humans; Hydrocodone; Illicit Drugs; Incidence; Methadone; Opioid-Related Disorders; Oxycodone; Substance-Related Disorders; Wisconsin | 2019 |
Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice.
Topics: Analgesics, Opioid; Animals; Benzimidazoles; Imidazoles; Ligands; Male; Mice; Mice, Inbred C57BL; Morphine; Naloxone; Nociceptin Receptor; Opioid-Related Disorders; Oxycodone; Piperidines; Receptors, Opioid; Spiro Compounds | 2018 |
Scoring the best deal: Quantity discounts and street price variation of diverted oxycodone and oxymorphone.
Topics: Commerce; Cross-Sectional Studies; Drug Overdose; Humans; Illicit Drugs; Narcotics; Opioid-Related Disorders; Oxycodone; Oxymorphone; Prescription Drug Diversion; Prospective Studies; United States | 2019 |
Continuous local bupivacaine wound infusion with neuraxial morphine reduces opioid consumption after cesarean delivery.
Topics: Acetaminophen; Adult; Analgesia, Epidural; Analgesia, Obstetrical; Analgesics, Opioid; Anesthesia, Spinal; Anesthetics, Local; Bupivacaine; Cesarean Section; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Ibuprofen; Morphine; Opioid-Related Disorders; Oxycodone; Pain Management; Pain, Postoperative; Pregnancy; Retrospective Studies; Surgical Wound; Young Adult | 2019 |
Prophylactic vaccination protects against the development of oxycodone self-administration.
Topics: Analgesics, Opioid; Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Immunoconjugates; Male; Motivation; Nociception; Opioid-Related Disorders; Oxycodone; Rats, Wistar; Self Administration; Vaccination | 2018 |
Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza
Topics: Analgesics, Opioid; Delayed-Action Preparations; Drug Compounding; Drug Liberation; Humans; Opioid-Related Disorders; Oxycodone | 2018 |
Response to Crudele et al. Commentary on Mayock et al. "In Vitro Drug Release after Crushing: Evaluation of Xtampza
Topics: Analgesics, Opioid; Delayed-Action Preparations; Drug Compounding; Drug Liberation; Humans; Opioid-Related Disorders; Oxycodone | 2018 |
Incidence of nonmedical use of OxyContin and other prescription opioid pain relievers before and after the introduction of OxyContin with abuse deterrent properties.
Topics: Adolescent; Analgesics, Opioid; Commerce; Female; Humans; Illicit Drugs; Incidence; Male; Narcotics; Opioid-Related Disorders; Oxycodone; Pain; United States; Young Adult | 2018 |
Methylnaltrexone-Associated Bowel Perforation in Postoperative Opioid-Induced Constipation and Ogilvie Syndrome: A Case Report.
Topics: Analgesics, Opioid; Colonic Pseudo-Obstruction; Constipation; Decompression, Surgical; Humans; Hydromorphone; Intestinal Perforation; Low Back Pain; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Postoperative Complications; Quaternary Ammonium Compounds; Spinal Stenosis | 2019 |
Prescription opioid analgesic use in France: Trends and impact on morbidity-mortality.
Topics: Adult; Aged; Analgesics, Opioid; Chronic Pain; Codeine; Databases, Factual; Dextropropoxyphene; Female; Fentanyl; France; Humans; Male; Middle Aged; Mortality; Opioid-Related Disorders; Opium; Oxycodone; Prevalence; Proportional Hazards Models; Tramadol | 2019 |
Chronic Oxycodone Self-administration Altered Reward-related Genes in the Ventral and Dorsal Striatum of C57BL/6J Mice: An RNA-seq Analysis.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Gene Expression; Male; Mice, Inbred C57BL; Opioid-Related Disorders; Oxycodone; Reward; Self Administration; Sequence Analysis, RNA; Ventral Striatum | 2018 |
Conditional power for assessing population interventions.
Topics: Analgesics, Opioid; Capsules; Delayed-Action Preparations; Drug Compounding; Humans; Opioid-Related Disorders; Oxycodone; Population Surveillance; Tablets; United States | 2018 |
Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins.
Topics: Adjuvants, Immunologic; Animals; Brain; Carrier Proteins; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Overdose; Haptens; Hemocyanins; Heroin; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nociception; Opioid-Related Disorders; Oxycodone; Tissue Distribution; Vaccines, Conjugate | 2018 |
Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS.
Topics: Buprenorphine; Cannabinoids; Chromatography, Liquid; Humans; Hydrocodone; Hydromorphone; Illicit Drugs; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Oxymorphone; Retrospective Studies; Saliva; Substance Abuse Detection; Tandem Mass Spectrometry | 2018 |
Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled Study.
Topics: Adult; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Pentazocine; Placebos | 2019 |
What are our aims, and why?
Topics: Abuse-Deterrent Formulations; Humans; Marketing; Opioid-Related Disorders; Oxycodone | 2019 |
Benchmarks of Duration and Magnitude of Opioid Consumption After Total Hip and Knee Arthroplasty: A Database Analysis of 69,368 Patients.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benchmarking; Databases, Factual; Female; Humans; Knee Joint; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Postoperative Period; Practice Patterns, Physicians'; Retrospective Studies; Risk Factors | 2019 |
Adolescent Nonmedical Use of Opioids and Alcohol Mixed with Energy Drinks.
Topics: Acetaminophen; Adolescent; Adolescent Behavior; Alcohol Drinking; Analgesics, Opioid; Drinking Behavior; Drug Combinations; Energy Drinks; Female; Humans; Hydrocodone; Male; Opioid-Related Disorders; Oxycodone; Underage Drinking | 2018 |
A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C.
Topics: Analgesics, Opioid; Hepacivirus; Hepatitis C; Humans; Illicit Drugs; Injections, Intravenous; Opioid Epidemic; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; United States | 2019 |
Case 6-2019: A 29-Year-Old Woman with Nausea, Vomiting, and Diarrhea.
Topics: Acetaminophen; Adult; Buprenorphine; Cocaine-Related Disorders; Diagnosis, Differential; Diarrhea; Drug Combinations; Female; Humans; Illicit Drugs; Naloxone; Narcotic Antagonists; Nausea; Opioid-Related Disorders; Oxycodone; Substance Abuse Detection; Vomiting | 2019 |
Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analgesics, Opioid; Australia; Buprenorphine; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Prescriptions; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Opioid Epidemic; Opioid-Related Disorders; Oxycodone; Pain; Policy Making; Practice Patterns, Physicians'; Sex Factors; Transdermal Patch; Young Adult | 2019 |
Oxycodone's Unparalleled Addictive Potential: Is it Time for a Moratorium?
Topics: Adult; Alaska; Analgesics, Opioid; Cross-Sectional Studies; Dopamine Agents; Female; Heroin Dependence; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Pain Management; Prescription Drug Misuse; Reward | 2019 |
Controlled-release opioids cause harm and should be avoided in management of postoperative pain in opioid naïve patients.
Topics: Administration, Oral; Analgesics, Opioid; Delayed-Action Preparations; Humans; Opioid-Related Disorders; Oxycodone; Pain Management; Pain, Postoperative; Prescription Drug Overuse | 2019 |
Abuse-Deterrent Opioids: The Authors Reply.
Topics: Analgesics, Opioid; Chronic Pain; Hepatitis C; Humans; Opioid-Related Disorders; Oxycodone | 2019 |
Delta-opioid receptor antagonist naltrindole reduces oxycodone addiction and constipation in mice.
Topics: Analgesics; Animals; Constipation; Drug Tolerance; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Receptors, Opioid, delta; Respiratory Insufficiency | 2019 |
Persistence with opioids post discharge from hospitalisation for surgery in Australian adults: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Australia; Databases, Factual; Drug Prescriptions; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Naloxone; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Patient Discharge; Retrospective Studies; Risk Factors; Young Adult | 2019 |
Formulation and Characterization of Conjugate Vaccines to Reduce Opioid Use Disorders Suitable for Pharmaceutical Manufacturing and Clinical Evaluation.
Topics: Animals; Hemocyanins; Heroin; Humans; Opioid-Related Disorders; Oxycodone; Rats; Vaccines; Vaccines, Conjugate | 2019 |
Descriptive, observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Cocaine; Crime; Drug Overdose; Drug Users; Female; Fentanyl; Humans; Hydrocodone; Hypnotics and Sedatives; Law Enforcement; Maine; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Sex Distribution; Young Adult | 2019 |
Escalated Oxycodone Self-Administration Causes Differential Striatal mRNA Expression of FGFs and IEGs Following Abstinence-Associated Incubation of Oxycodone Craving.
Topics: Animals; Behavior, Addictive; Corpus Striatum; Craving; Fibroblast Growth Factors; Genes, Immediate-Early; Male; Models, Animal; Nucleus Accumbens; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; RNA, Messenger; Self Administration; Substance Withdrawal Syndrome | 2019 |
Ask the doctors. I have had back problems for decades, and I have become quite dependent on oxycodone, regardless of whether my back is acting up or not. Now I am going to need heart surgery, but the surgeon I was sent to won't operate unless I can get of
Topics: Back Pain; Cardiac Surgical Procedures; Health Behavior; Health Status; Heart Diseases; Humans; Opioid-Related Disorders; Oxycodone; Preoperative Care; Withholding Treatment | 2012 |
Recent trends in substance abuse among persons with disabilities compared to that of persons without disabilities.
Topics: Adolescent; Adult; Alcoholism; Cocaine-Related Disorders; Disabled Persons; Female; Health Surveys; Humans; Logistic Models; Male; Marijuana Abuse; Middle Aged; Opioid-Related Disorders; Oxycodone; Prevalence; Self Report; Substance-Related Disorders; Young Adult | 2013 |
Reply to commentary.
Topics: Analgesics, Opioid; Female; Humans; Male; Opioid-Related Disorders; Oxycodone | 2013 |
Is there support for abuse-deterrent and tamper-resistant opioid formulations?
Topics: Analgesics, Opioid; Female; Humans; Male; Opioid-Related Disorders; Oxycodone | 2013 |
Aglukkaq asks for US help to control oxycodone.
Topics: Analgesics, Opioid; Canada; Drug and Narcotic Control; Drugs, Generic; Humans; Opioid-Related Disorders; Oxycodone; United States | 2013 |
Hope in Fort Hope: First Nations community is winning the battle against prescription drug abuse.
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Indians, North American; Male; Naloxone; Narcotic Antagonists; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse | 2013 |
Opioid withdrawal syndrome after treatment with low-dose extended-release oxycodone and naloxone in a gastric cancer patient with portal vein thrombosis.
Topics: Abdominal Pain; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Portal Vein; Stomach Neoplasms; Substance Withdrawal Syndrome; Treatment Outcome; Venous Thrombosis | 2013 |
Toward primary prevention of extra-medical OxyContin® use among young people.
Topics: Adolescent; Age Factors; Analgesics, Opioid; Chemistry, Pharmaceutical; Child; Female; Humans; Incidence; Male; Opioid-Related Disorders; Oxycodone; Primary Prevention; United States; Young Adult | 2013 |
Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Buprenorphine; Chronic Pain; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Statistics, Nonparametric | 2013 |
Timed-release oxycodone.
Topics: Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse | 2013 |
Attractiveness of reformulated OxyContin(R) tablets: assessing comparative preferences and tampering potential.
Topics: Adult; Analgesics, Opioid; Chemistry, Pharmaceutical; Delayed-Action Preparations; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; Tablets | 2013 |
Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study.
Topics: Adult; Aged; Analgesics, Opioid; Cohort Studies; Databases, Factual; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; International Classification of Diseases; Male; Middle Aged; Odds Ratio; Opioid-Related Disorders; Oxycodone; Pain; Phenols; Propensity Score; Retrospective Studies; Risk; Sample Size; Tapentadol | 2013 |
Elevated acetaminophen concentration measured after nasal insufflation of Percocet®.
Topics: Acetaminophen; Acetylcysteine; Administration, Intranasal; Adult; Drug Combinations; Drug Overdose; Female; Free Radical Scavengers; Humans; Insufflation; Nose; Opioid-Related Disorders; Oxycodone | 2013 |
Rational prescribing.
Topics: Acetaminophen; Analgesics, Opioid; Chronic Pain; Drug Combinations; Humans; Long-Term Care; Minnesota; Opioid-Related Disorders; Oxycodone; Pain Measurement; Practice Patterns, Physicians'; Prescription Drug Misuse | 2013 |
Generic controlled-release oxycodone.
Topics: Analgesics, Opioid; Drug and Narcotic Control; Humans; Opioid-Related Disorders; Oxycodone | 2013 |
Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics.
Topics: Analgesics, Opioid; Delayed-Action Preparations; Heroin; Humans; Logistic Models; Models, Structural; Opioid-Related Disorders; Oxycodone; Poison Control Centers; Prescription Drug Misuse; United States | 2013 |
Self administration of oxycodone by adolescent and adult mice affects striatal neurotransmitter receptor gene expression.
Topics: Age Factors; Animals; Corpus Striatum; Drug-Seeking Behavior; Gene Expression; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Narcotics; Opioid-Related Disorders; Oxycodone; Real-Time Polymerase Chain Reaction; Receptors, Neuropeptide Y; Receptors, Neurotransmitter; RNA, Messenger; Self Administration | 2014 |
From oxycodone to heroin: two cases of transitioning opioid use in young Australians.
Topics: Administration, Intravenous; Adult; Australia; Drug Users; Female; Heroin; Humans; Male; Methadone; Opioid-Related Disorders; Oxycodone; Self Medication; Substance Abuse, Intravenous; Young Adult | 2014 |
Factors influencing the selection of hydrocodone and oxycodone as primary opioids in substance abusers seeking treatment in the United States.
Topics: Adolescent; Adult; Analgesics, Opioid; Chemistry, Pharmaceutical; Data Collection; Female; Follow-Up Studies; Humans; Hydrocodone; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Substance Abuse Treatment Centers; United States; Young Adult | 2013 |
Changes in prevalence of prescription opioid abuse after introduction of an abuse-deterrent opioid formulation.
Topics: Adolescent; Adult; Analgesics, Opioid; Cross-Sectional Studies; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Oxymorphone; Prevalence; Young Adult | 2014 |
Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse.
Topics: Adult; Aged; Analgesics, Opioid; Cohort Studies; Databases, Factual; Drug Prescriptions; Drug-Seeking Behavior; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Phenols; Sex Factors; Tapentadol; United States | 2014 |
Oxycodone insufflation resulting in nasal septal abscess.
Topics: Abscess; Adult; Female; Humans; Insufflation; Narcotics; Nasal Septum; Nose Diseases; Opioid-Related Disorders; Oxycodone; Pain | 2014 |
The CYP2D6 gene determines oxycodone's phenotype-specific addictive potential: implications for addiction prevention and treatment.
Topics: Cytochrome P-450 CYP2D6; Genetic Predisposition to Disease; Humans; Opioid-Related Disorders; Oxycodone; Phenotype | 2014 |
Evaluation of the resistance of a geopolymer-based drug delivery system to tampering.
Topics: Administration, Oral; Analgesics, Opioid; Chemistry, Pharmaceutical; Compressive Strength; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Users; Humans; Opioid-Related Disorders; Oxycodone; Polymers; Solubility; Solvents; Tablets; Technology, Pharmaceutical; Temperature; Time Factors | 2014 |
Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US.
Topics: Adult; Analgesics, Opioid; Cost Savings; Delayed-Action Preparations; Female; Health Services; Humans; Insurance Claim Review; Male; Medicaid; Medicare; Middle Aged; Opioid-Related Disorders; Oxycodone; Pain; United States | 2014 |
Trends and changes in prescription opioid analgesic dispensing in Canada 2005-2012: an update with a focus on recent interventions.
Topics: Analgesics, Opioid; Canada; Drug Prescriptions; Humans; Opioid-Related Disorders; Oxycodone; Pharmacies; Practice Patterns, Physicians' | 2014 |
OxyContin in Ontario: the multiple materialities of prescription painkillers.
Topics: Analgesics, Opioid; Humans; Ontario; Opioid-Related Disorders; Oxycodone; Pain; Public Health | 2014 |
The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers.
Topics: Adult; Delayed-Action Preparations; Female; Humans; Interviews as Topic; Male; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; Prevalence | 2014 |
Use of prescription opioids with abuse-deterrent technology to address opioid abuse.
Topics: Adolescent; Adult; Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Oxymorphone; Patient Acceptance of Health Care; United States; Young Adult | 2014 |
Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats.
Topics: Analgesics, Opioid; Animals; Drug Evaluation, Preclinical; Freund's Adjuvant; Haptens; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vaccines, Conjugate | 2014 |
Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuse.
Topics: Acetaminophen; Analgesics, Opioid; Chemistry, Pharmaceutical; Drug Combinations; Humans; Hydrocodone; Hydromorphone; Internet; Opioid-Related Disorders; Oxycodone; Social Media | 2014 |
Rapid-onset opioids for the treatment of breakthrough cancer pain: two cases of drug abuse.
Topics: Analgesics, Opioid; Breakthrough Pain; Chemoradiotherapy; Coma; Fentanyl; Gastrointestinal Stromal Tumors; Humans; Male; Nasopharyngeal Neoplasms; Opioid-Related Disorders; Oxycodone; Palliative Care; Tramadol; Young Adult | 2014 |
Oxycodone recycling: a novel hypothesis of opioid tolerance development in humans.
Topics: Administration, Oral; Adult; Alleles; Analgesics, Opioid; Biological Transport; Cytochrome P-450 CYP2D6; Drug Tolerance; Genotype; Humans; Kinetics; Male; Opioid-Related Disorders; Oxycodone; Phenotype; Receptors, Opioid, mu; Time Factors; Young Adult | 2014 |
Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats.
Topics: Analgesics, Opioid; Animals; Antibody Specificity; Brain; Gene Expression Profiling; Gene Expression Regulation; Haptens; Immunization; Immunoglobulin G; Male; Opioid-Related Disorders; Oxycodone; Rats; Self Administration; Vaccines, Conjugate | 2014 |
Societal economic benefits associated with an extended-release opioid with abuse-deterrent technology in the United States.
Topics: Absenteeism; Analgesics, Opioid; Chemistry, Pharmaceutical; Cost of Illness; Cost Savings; Criminal Law; Delayed-Action Preparations; Drug Costs; Drug Labeling; Health Care Costs; Health Expenditures; Humans; Opioid-Related Disorders; Oxycodone; Research; Technology, Pharmaceutical; United States; United States Food and Drug Administration | 2014 |
Potential cost-shifting and hidden costs and risks in the economic analysis of opioid abuse-deterrent formulations.
Topics: Analgesics, Opioid; Chemistry, Pharmaceutical; Cost of Illness; Humans; Opioid-Related Disorders; Oxycodone; Technology, Pharmaceutical | 2014 |
Compulsive-like responding for opioid analgesics in rats with extended access.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Drug-Seeking Behavior; Fentanyl; Heroin; Male; Opioid-Related Disorders; Oxycodone; Rats, Wistar; Self Administration; Time Factors | 2015 |
Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Australia; Chemistry, Pharmaceutical; Humans; Illicit Drugs; Medication Adherence; Middle Aged; Opioid-Related Disorders; Oxycodone; Prescription Drug Diversion; Prescription Drug Misuse; Product Surveillance, Postmarketing; Prospective Studies; Young Adult | 2015 |
Kentucky seeks $1bn from Purdue Pharma for misrepresenting addictive potential of oxycodone.
Topics: Drug Industry; Humans; Kentucky; Marketing; Narcotics; Opioid-Related Disorders; Oxycodone | 2014 |
Impact of abuse-deterrent OxyContin on prescription opioid utilization.
Topics: Analgesics, Opioid; Commerce; Delayed-Action Preparations; Humans; Opioid-Related Disorders; Oxycodone; Prescriptions; Substance-Related Disorders; Time Factors; United States | 2015 |
An update on oxycodone: lessons for death investigators in Australia.
Topics: Adolescent; Adult; Age Factors; Aged; Analgesics, Opioid; Australia; Autopsy; Cause of Death; Child; Child, Preschool; Comorbidity; Databases, Factual; Drug Interactions; Drug Overdose; Female; Forensic Toxicology; Humans; Inappropriate Prescribing; Infant; Infant, Newborn; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Young Adult | 2015 |
Self administration of oxycodone alters synaptic plasticity gene expression in the hippocampus differentially in male adolescent and adult mice.
Topics: Aging; Animals; Cadherins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP Response Element Modulator; Gene Expression; Gene Expression Regulation, Developmental; Hippocampus; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Narcotics; Opioid-Related Disorders; Oxycodone; Proto-Oncogene Proteins c-pim-1; Receptor, Metabotropic Glutamate 5; Receptors, AMPA; RNA, Messenger; Self Administration | 2015 |
Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series.
Topics: Adult; Codeine; Female; Humans; Male; Methadone; Middle Aged; Morphine; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Patient Acceptance of Health Care; Retrospective Studies | 2015 |
Trends in opioid analgesic abuse and mortality in the United States.
Topics: Analgesics, Opioid; Drug and Narcotic Control; Drug Prescriptions; Drug Utilization; Heroin Dependence; Humans; Opioid-Related Disorders; Oxycodone; Prescription Drug Diversion; Product Surveillance, Postmarketing; United States | 2015 |
Commentary on Degenhardt et al (2015): a new formulation for research.
Topics: Analgesics, Opioid; Chemistry, Pharmaceutical; Humans; Opioid-Related Disorders; Oxycodone | 2015 |
Evaluation of an Extended-Release, Abuse-Deterrent, Microsphere-in-Capsule Analgesic for the Management of Patients with Chronic Pain With Dysphagia (CPD).
Topics: Adult; Analgesics, Opioid; Capsules; Chemistry, Pharmaceutical; Chronic Pain; Deglutition; Deglutition Disorders; Delayed-Action Preparations; Food; Humans; Intubation, Gastrointestinal; Microspheres; Opioid-Related Disorders; Oxycodone; Pain Management | 2016 |
Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
Topics: Adult; Analgesics, Opioid; Chemistry, Pharmaceutical; Female; Humans; Interview, Psychological; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Prescription Drugs; Surveys and Questionnaires; United States | 2015 |
Dexmedetomidine, ketamine, and midazolam for oral rehabilitation: a case report.
Topics: Adult; Analgesics, Opioid; Anesthesia, Dental; Anesthetics, Combined; Anesthetics, Dissociative; Anesthetics, Intravenous; Deep Sedation; Dental Anxiety; Dental Care for Chronically Ill; Dental Caries; Dental Restoration, Permanent; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Ketamine; Midazolam; Opioid-Related Disorders; Oxycodone; Tooth Extraction | 2015 |
The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study.
Topics: Australia; Chemistry, Pharmaceutical; Cohort Studies; Commerce; Female; Humans; Male; Narcotics; Needle-Exchange Programs; Opioid-Related Disorders; Oxycodone; Pharmacies | 2015 |
Effectiveness of opioid analgesics in chronic noncancer pain.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Fentanyl; Humans; Hydromorphone; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Opioid-Related Disorders; Oxycodone; Pain Clinics; Pain Measurement; Personality; Phenols; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tapentadol; Treatment Outcome | 2015 |
A 37-year-old man with chronic low back pain and substance abuse.
Topics: Adult; Alcohol-Related Disorders; Chronic Pain; Humans; Low Back Pain; Male; Opioid-Related Disorders; Oxycodone; Risk Factors | 2015 |
Does therapeutic use of tapentadol cause false-positive urine screens for methadone or opiates?
Topics: Adult; Aged, 80 and over; Analgesics, Opioid; Chromatography, Gas; Chromatography, Liquid; False Positive Reactions; Female; Humans; Hydrocodone; Immunoenzyme Techniques; Male; Methadone; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Phenols; Predictive Value of Tests; Reproducibility of Results; Substance Abuse Detection; Tandem Mass Spectrometry; Tapentadol; Urinalysis | 2015 |
The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse.
Topics: Animals; Antibodies; Antibody Specificity; B-Lymphocyte Subsets; Disease Models, Animal; Germinal Center; Haptens; Humans; Immunization; Lymphocyte Activation; Lymphocyte Count; Male; Mice; Opioid-Related Disorders; Oxycodone; Spleen; T-Lymphocyte Subsets; Vaccines | 2015 |
"Sub is a weird drug:" A web-based study of lay attitudes about use of buprenorphine to self-treat opioid withdrawal symptoms.
Topics: Adult; Attitude to Health; Buprenorphine, Naloxone Drug Combination; Cross-Sectional Studies; Female; Health Surveys; Humans; Hydrocodone; Internet; Middle Aged; Opioid-Related Disorders; Oxycodone; Self Medication; Substance Withdrawal Syndrome; Treatment Outcome | 2015 |
The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain.
Topics: Acetaminophen; Acute Pain; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Combinations; Humans; Ireland; Male; Opioid-Related Disorders; Oxycodone; Pain Management; Pain, Postoperative | 2015 |
Opioid Overdose Deaths in the City and County of San Francisco: Prevalence, Distribution, and Disparities.
Topics: Adolescent; Adult; Aged; Black or African American; Cocaine; Drug Overdose; Female; Health Status Disparities; Humans; Male; Methadone; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Poverty Areas; Prevalence; San Francisco; Socioeconomic Factors; Young Adult | 2015 |
Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids.
Topics: Adult; Alcoholism; Analgesics, Opioid; Female; Humans; Interviews as Topic; Male; Methods; Morphine Dependence; New South Wales; Opioid-Related Disorders; Oxycodone; Pain; Prescription Drug Misuse; South Australia; Substance Abuse, Intravenous; Tasmania | 2015 |
A case of rhabdomyolysis associated with severe opioid withdrawal.
Topics: Acute Kidney Injury; Administration, Intranasal; Administration, Oral; Administration, Sublingual; Analgesics, Opioid; Buprenorphine, Naloxone Drug Combination; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Intensive Care Units; Male; Opioid-Related Disorders; Oxycodone; Oxymorphone; Prescription Drugs; Rhabdomyolysis; Self Medication; Substance Withdrawal Syndrome; Young Adult | 2015 |
Technology: Barriers to misuse.
Topics: Analgesics, Opioid; Chemistry, Pharmaceutical; Drug Combinations; Drug Overdose; Drug Users; Humans; Morphine; Naltrexone; Opioid-Related Disorders; Oxycodone; Prodrugs | 2015 |
Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets.
Topics: Acetaminophen; Acute Pain; Administration, Intranasal; Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Drug Compounding; Humans; Opioid-Related Disorders; Oxycodone; Pain Management; Particle Size; Solubility; Solvents; Stress, Mechanical; Tablets | 2016 |
Abuse-Deterrent Formulations of Prescription Opioids.
Topics: Analgesics, Opioid; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Prescription Drugs | 2015 |
Abuse-Deterrent Formulations of Prescription Opioids.
Topics: Analgesics, Opioid; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Prescription Drugs | 2015 |
Abuse Deterrent Formulations of Prescription Opioids--Reply.
Topics: Analgesics, Opioid; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Prescription Drugs | 2015 |
Acute opioid administration induces hypothalamic-pituitary-adrenal activation and is mediated by genetic variation in interleukin (Il)1B.
Topics: Alleles; Analgesics, Opioid; Female; Genetic Variation; Genotype; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Interleukin-1beta; Male; Opioid-Related Disorders; Oxycodone; Pituitary-Adrenal System; Polymorphism, Single Nucleotide; Pupil; Young Adult | 2015 |
A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone.
Topics: Adult; Analgesics, Opioid; Behavior, Addictive; Chemistry, Pharmaceutical; Dosage Forms; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; Psychometrics | 2015 |
[Nalmefene and Opioid Withdrawal Syndrome: Analysis of the Global Pharmacovigilance Database for Adverse Drug Reactions].
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Alcoholism; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Pharmacovigilance; Substance Withdrawal Syndrome | 2015 |
Effects of Acute and Repeated Administration of Oxycodone and Naloxone-Precipitated Withdrawal on Intracranial Self-Stimulation in Rats.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Drug Tolerance; Electrodes, Implanted; Infusions, Subcutaneous; Male; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Self Stimulation; Substance Withdrawal Syndrome | 2016 |
Companies to pay $39.5m in OxyContin and Risperdal cases.
Topics: Analgesics, Opioid; Compensation and Redress; Consumer Product Safety; Dopamine Antagonists; Drug Industry; Humans; Liability, Legal; Opioid-Related Disorders; Oxycodone; Product Surveillance, Postmarketing; Risperidone; United States | 2015 |
Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone.
Topics: Analgesics; Analgesics, Opioid; Codeine; Drug and Narcotic Control; Government Regulation; Heroin; Humans; Hydrocodone; Opioid-Related Disorders; Oxycodone; Poison Control Centers; Prescription Drug Misuse; Texas; Tramadol | 2016 |
OVERDOSED ON OPIOIDS: A deadly opioid epidemic sweeping the country has lawmakers working hard to find solutions.
Topics: Analgesics, Opioid; Drug Overdose; Heroin; Humans; Legislation, Drug; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Prescription Drugs; United States | 2016 |
The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.
Topics: Analgesics, Opioid; Chemistry, Pharmaceutical; Drug Administration Routes; Humans; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Prescription Drug Diversion; Prescription Drug Misuse; Product Surveillance, Postmarketing; Residence Characteristics; United States | 2016 |
Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties.
Topics: Analgesics, Opioid; Delivery of Health Care, Integrated; Drug Compounding; Drug Overdose; Electronic Health Records; Humans; Opioid-Related Disorders; Oxycodone; Product Surveillance, Postmarketing | 2016 |
A tale of 2 ADFs: differences in the effectiveness of abuse-deterrent formulations of oxymorphone and oxycodone extended-release drugs.
Topics: Adult; Analgesics, Opioid; Delayed-Action Preparations; Drug Compounding; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Oxymorphone; Pain; Treatment Outcome | 2016 |
Substance Abuse and Tooth Destruction.
Topics: Adult; Alcoholism; Amphetamine-Related Disorders; Carbonated Beverages; Cocaine-Related Disorders; Dental Caries; Dental Restoration, Permanent; Denture, Complete; Denture, Partial; Female; Gingivitis; Humans; Male; Marijuana Abuse; Methamphetamine; Middle Aged; Narcotics; Opioid-Related Disorders; Oxycodone; Periodontitis; Substance-Related Disorders; Tooth Diseases | 2016 |
FDA Approval of Extended-Release Oxycodone for Children With Severe Pain.
Topics: Adolescent; Analgesics, Opioid; Child; Chronic Pain; Delayed-Action Preparations; Drug Approval; Humans; Opioid-Related Disorders; Oxycodone; Severity of Illness Index; United States; United States Food and Drug Administration | 2016 |
Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Female; Humans; Male; Methadone; Middle Aged; Morphine Dependence; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Retrospective Studies | 2017 |
A new abuse-deterrent opioid--Xtampza ER.
Topics: Administration, Oral; Analgesics, Opioid; Capsules; Delayed-Action Preparations; Drug Administration Schedule; Drug Compounding; Drug Interactions; Humans; Opioid-Related Disorders; Oxycodone; Pain; Severity of Illness Index | 2016 |
Discordant reporting of nonmedical opioid use in a nationally representative sample of US high school seniors.
Topics: Acetaminophen; Adolescent; Analgesics, Opioid; Drug Combinations; Female; Humans; Hydrocodone; Male; Opioid-Related Disorders; Oxycodone; Prevalence; Reproducibility of Results; Schools; Self Report; Students; United States; Young Adult | 2016 |
Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin).
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Cohort Studies; Delayed-Action Preparations; Drug Compounding; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Pharmacies; Physicians; Prescription Drug Diversion; Prescription Drug Misuse; Prescriptions; Young Adult | 2016 |
Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment.
Topics: Animals; Behavior, Animal; Conditioning, Psychological; Dopamine Antagonists; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Locomotion; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Opioid-Related Disorders; Oxycodone; Rats; Rats, Long-Evans; Receptors, Dopamine D3; Salicylamides; Structure-Activity Relationship | 2016 |
Trends in the Nonmedical Use of OxyContin, United States, 2006 to 2013.
Topics: Adolescent; Adult; Child; Female; Humans; Illicit Drugs; Logistic Models; Male; Multivariate Analysis; Narcotics; Opioid-Related Disorders; Oxycodone; Prevalence; United States; Young Adult | 2017 |
Opioid rain: opioid prescribing is growing and practice is diverging.
Topics: Analgesics, Opioid; Drug Prescriptions; Humans; New Zealand; Opioid-Related Disorders; Oxycodone; Patient Safety; Practice Patterns, Physicians'; Prescription Drug Misuse | 2016 |
Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.
Topics: Analgesics, Opioid; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Compounding; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Prescription Drug Diversion; Prescription Drug Misuse; Prescription Fees; Social Media; Surveys and Questionnaires; United States | 2016 |
Hippocrates and Targin.
Topics: Advertising; Analgesics, Opioid; Drug Combinations; Drug Industry; Humans; Naloxone; Opioid-Related Disorders; Oxycodone; Periodicals as Topic | 2016 |
High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study.
Topics: Adolescent; Adult; Analgesics, Opioid; Canada; Drug Administration Schedule; Female; Fentanyl; Hospitalization; Humans; Male; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Young Adult | 2016 |
In response to Gudin et al. - Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties.
Topics: Analgesics, Opioid; Delayed-Action Preparations; Humans; Opioid-Related Disorders; Oxycodone | 2017 |
Response to Crudele et al. Commentary on Gudin et al. "Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties".
Topics: Analgesics, Opioid; Delayed-Action Preparations; Humans; Opioid-Related Disorders; Oxycodone | 2017 |
An Advance in Prescription Opioid Vaccines: Overdose Mortality Reduction and Extraordinary Alteration of Drug Half-Life.
Topics: Analgesics, Opioid; Animals; Antibody Formation; Drug Overdose; Half-Life; Haptens; Humans; Hydrocodone; Mice; Opioid-Related Disorders; Oxycodone; Tetanus Toxoid; Vaccination; Vaccines | 2017 |
Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats.
Topics: Aminopyridines; Animals; Behavior, Animal; Benzazepines; Conditioning, Operant; Cues; Indoles; Male; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2017 |
Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.
Topics: Adult; Benzodiazepines; Buprenorphine; Cocaine; Community Health Services; Counseling; Drug Therapy, Combination; Female; Humans; Indians, North American; Male; Medication Adherence; Middle Aged; Morphine; Naloxone; Narcotic Antagonists; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Program Evaluation; Retrospective Studies; Rural Health Services; Substance Abuse Detection; Suicide; Young Adult | 2017 |
Treatment of Prescription Opioid Use Disorder in Pregnant Women.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Cognitive Behavioral Therapy; Female; Humans; Opioid-Related Disorders; Oxycodone; Pregnancy; Pregnancy Complications; Treatment Outcome | 2017 |
Effects of Short-Term Oxycodone Maintenance on Experimental Pain Responses in Physically Dependent Opioid Abusers.
Topics: Adult; Analgesia; Analgesics, Opioid; Drug Administration Schedule; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Pain | 2017 |
The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Health Surveys; Humans; Hydrocodone; Male; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Statistics as Topic; United States; Utilization Review | 2008 |
Prescription Opioid Misuse Index: a brief questionnaire to assess misuse.
Topics: Adult; Alcohol-Related Disorders; Analgesics, Opioid; Female; Humans; Illicit Drugs; Male; Opioid-Related Disorders; Oxycodone; Pain; Prisoners; Risk Factors; ROC Curve; Substance Abuse Detection; Substance-Related Disorders; Surveys and Questionnaires | 2008 |
Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population.
Topics: Adolescent; Adult; Analgesics, Opioid; Anxiety Disorders; Child; Delayed-Action Preparations; Depressive Disorder; Ethnicity; Female; Humans; Male; Mental Disorders; Mental Health; Opioid-Related Disorders; Oxycodone; Socioeconomic Factors; Substance-Related Disorders; United States; Young Adult | 2009 |
Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).
Topics: Analgesia; Analgesics, Opioid; Animals; Anti-Bacterial Agents; Brain; Bronchodilator Agents; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Immunohistochemistry; Injections, Intraperitoneal; Male; Minocycline; Morphine; Naloxone; Opioid-Related Disorders; Oxycodone; Pain; Pain Measurement; Pyridines; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Weight Loss | 2009 |
Trends in opioid consumption in the Nordic countries 2002-2006.
Topics: Analgesics, Opioid; Databases, Factual; Denmark; Dextropropoxyphene; Drug Administration Routes; Drug and Narcotic Control; Drug Costs; Drug Prescriptions; Drug Utilization; Fentanyl; Finland; Humans; Iceland; Needs Assessment; Norway; Opioid-Related Disorders; Oxycodone; Pain; Product Surveillance, Postmarketing; Registries; Reimbursement Mechanisms; Scandinavian and Nordic Countries | 2009 |
Profound hearing loss associated with oxycodone-acetaminophen abuse.
Topics: Acetaminophen; Drug Combinations; Female; Hearing Loss, Sensorineural; Humans; Middle Aged; Opioid-Related Disorders; Oxycodone | 2008 |
Changing patterns in opioid addiction: characterizing users of oxycodone and other opioids.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Drug Utilization; Female; Humans; Male; Middle Aged; Ontario; Opioid-Related Disorders; Oxycodone; Retrospective Studies; Substance Abuse Treatment Centers; Young Adult | 2009 |
Trauma, dissociation, and substance dependence in an adolescent male.
Topics: Adolescent; Analgesics, Opioid; Cognitive Behavioral Therapy; Combined Modality Therapy; Dissociative Disorders; Humans; Male; Motivation; Opioid-Related Disorders; Oxycodone; Rape; Secondary Prevention; Social Adjustment; Stress Disorders, Post-Traumatic; Substance Abuse Detection; Token Economy | 2009 |
Prolonged-release naloxone can cause systemic opioid withdrawal.
Topics: Analgesics, Opioid; Delayed-Action Preparations; Diarrhea; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Humans; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Patient Compliance; Practice Patterns, Physicians'; Substance Withdrawal Syndrome | 2009 |
Seeking drug treatment for OxyContin abuse: a chart review of consecutive admissions to a substance abuse treatment facility in Kentucky.
Topics: Adult; Analgesics, Opioid; Female; Hospitalization; Humans; Kentucky; Male; Opioid-Related Disorders; Oxycodone; Retrospective Studies; Substance Abuse Treatment Centers | 2003 |
Estimating attractiveness for abuse of a not-yet-marketed "abuse-deterrent" prescription opioid formulation.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Analgesics, Opioid; Chemistry, Pharmaceutical; Child; Counseling; Data Collection; Delayed-Action Preparations; Demography; Female; Humans; Injections; Male; Middle Aged; Models, Psychological; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Pentazocine; Prescription Drugs; Reproducibility of Results; Smoking; Young Adult | 2010 |
Abuse liability of oxycodone as a function of pain and drug use history.
Topics: Adult; Analgesics, Opioid; Anxiety; Cold Temperature; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Male; Opioid-Related Disorders; Oxycodone; Pain; Pain Measurement; Phenotype; Prescription Drugs; Pressure; Psychomotor Performance; Pupil; Reinforcement, Psychology; Self Administration; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2010 |
Improved oxymorphone detection in postmortem specimens.
Topics: Analgesics, Opioid; Cross Reactions; Diagnosis; Drug Overdose; Enzyme-Linked Immunosorbent Assay; Humans; Opioid-Related Disorders; Oxycodone; Oxymorphone; Substance Abuse Detection | 2010 |
Comment on Edlund et al "trends in use of opioids for chronic noncancer pain among individuals with mental health and substance abuse disorders: the TROUP study".
Topics: Analgesics, Opioid; Humans; Opioid-Related Disorders; Oxycodone; Veterans | 2010 |
Overprescription of postoperative narcotics: a look at postoperative pain medication delivery, consumption and disposal in urological practice.
Topics: Adult; Analgesics; Analgesics, Opioid; Cross-Sectional Studies; Drug Prescriptions; Drug Utilization; Drug Utilization Review; Female; Humans; Hydrocodone; Male; Middle Aged; Needs Assessment; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Population Surveillance; Postoperative Care; Practice Patterns, Physicians'; Risk Assessment; Severity of Illness Index; Surveys and Questionnaires; Urologic Surgical Procedures; Urology; Utah | 2011 |
Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999-2008.
Topics: Adult; Age Distribution; Analgesics, Opioid; Australia; Drug Prescriptions; Female; Forensic Toxicology; Heart Diseases; Humans; Kidney Diseases; Liver Diseases; Lung Diseases; Male; Marital Status; Middle Aged; Opioid-Related Disorders; Oxycodone; Psychotropic Drugs; Sex Distribution; Suicide | 2011 |
Inquest jury seeks to take prescription opioids off Ontario's streets.
Topics: Humans; Legislation, Drug; Narcotics; Ontario; Opioid-Related Disorders; Oxycodone; Prescription Drugs; Safety-Based Drug Withdrawals | 2011 |
OxyContin misuse on a reservation: qualitative reports by American Indians in talking circles.
Topics: Adolescent; Adult; Female; Humans; Indians, North American; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Prevalence; Qualitative Research | 2011 |
Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain.
Topics: Adult; Analgesics, Opioid; Bone Neoplasms; Breakthrough Pain; Fatal Outcome; Female; Fentanyl; Humans; Middle Aged; Neoplasms; Opioid-Related Disorders; Ovarian Neoplasms; Oxycodone; Terminal Care | 2011 |
Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population.
Topics: Analgesics, Opioid; Benzodiazepines; Canada; Chronic Pain; Codeine; Humans; Hydromorphone; Mass Screening; Opioid-Related Disorders; Oxycodone; Patient Education as Topic; Sleep Apnea Syndromes; Tramadol | 2011 |
Characteristics of chronic pain patients in a rural teaching practice.
Topics: Adult; Aged; Alcohol-Related Disorders; Analgesics, Opioid; Back Pain; Chronic Pain; Female; Health Status; Humans; Male; Middle Aged; Musculoskeletal Pain; Office Visits; Ontario; Opioid-Related Disorders; Oxycodone; Primary Health Care; Retrospective Studies; Rural Health Services; Tobacco Use Disorder | 2011 |
Narcotic-exposed neonates in a First Nations population in northwestern Ontario: incidence and implications.
Topics: Adolescent; Adult; Alcohol Drinking; Analgesics, Opioid; Female; Humans; Incidence; Indians, North American; Infant, Newborn; Length of Stay; Maternal-Fetal Exchange; Morphine; Neonatal Abstinence Syndrome; Ontario; Opioid-Related Disorders; Oxycodone; Pregnancy; Pregnancy Complications; Premature Birth; Retrospective Studies; Severity of Illness Index; Smoking; Young Adult | 2011 |
A brief survey to characterize oxycodone abuse patterns in adolescents enrolled in two substance abuse recovery high schools.
Topics: Administration, Intranasal; Adolescent; Age of Onset; Analgesics, Opioid; Female; Health Surveys; Humans; Male; Massachusetts; Opioid-Related Disorders; Oxycodone; Young Adult | 2012 |
Painful medicine.
Topics: Drug Industry; Humans; Narcotics; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; United States | 2011 |
Effect of yohimbine stress on reacquisition of oxycodone seeking in rats.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Conditioning, Psychological; Dose-Response Relationship, Drug; Male; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Recurrence; Self Administration; Stress, Psychological; Yohimbine | 2012 |
OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users.
Topics: Adult; Analgesics, Opioid; Drug Users; Female; Humans; Hydrocodone; Illicit Drugs; Interpersonal Relations; Kentucky; Male; Multilevel Analysis; Opioid-Related Disorders; Oxycodone; Rural Population; Sex Distribution; Social Support; Socioeconomic Factors; Substance-Related Disorders | 2012 |
Endogenous fungal endophthalmitis.
Topics: Antifungal Agents; Candidemia; Endophthalmitis; Eye Infections, Fungal; Humans; Male; Opioid-Related Disorders; Oxycodone; Substance Abuse, Intravenous; Vitrectomy; Vitreous Body; Young Adult | 2012 |
The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
Topics: Analgesics, Opioid; Buprenorphine; Drug and Narcotic Control; Drug Approval; Health Services Accessibility; Healthcare Disparities; Humans; Legislation, Drug; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Pain; Prescription Drugs; Substance-Related Disorders; United States; United States Food and Drug Administration | 2012 |
Nepenthe.
Topics: Adult; Analgesics, Opioid; Attitude of Health Personnel; Chronic Pain; Drug Overdose; Humans; Male; Opioid-Related Disorders; Oxycodone | 2012 |
Effect of abuse-deterrent formulation of OxyContin.
Topics: Chemistry, Pharmaceutical; Heroin Dependence; Humans; Opioid-Related Disorders; Oxycodone | 2012 |
Comparison of fatal poisonings by prescription opioids.
Topics: Accidents; Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Central Nervous System Depressants; Codeine; Dextropropoxyphene; Drug Overdose; Ethanol; Fentanyl; Finland; Forensic Toxicology; Humans; Hypnotics and Sedatives; Methadone; Morphine; Opioid-Related Disorders; Oxycodone; Poisoning; Prescription Drug Misuse; Suicide; Tramadol; Young Adult | 2012 |
Clinical history and characteristics of persons with oxycodone-related deaths in Hillsborough County, Florida in 2009.
Topics: Adult; Age Distribution; Aged; Alprazolam; Analgesics, Opioid; Central Nervous System Depressants; Drug Prescriptions; Ethanol; Female; Florida; Forensic Toxicology; Humans; Hypnotics and Sedatives; Male; Methadone; Middle Aged; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; Sex Distribution; Young Adult | 2012 |
'Opioid drought', Canadian-style? Potential implications of the 'natural experiment' of delisting oxycontin in Canada.
Topics: Analgesics, Opioid; Canada; Catchment Area, Health; Chemistry, Pharmaceutical; Drug and Narcotic Control; Government Regulation; Harm Reduction; Health Policy; Humans; Illicit Drugs; Opioid-Related Disorders; Oxycodone; Pharmacopoeias as Topic | 2012 |
My story: how one Percocet prescription triggered my addiction.
Topics: Acetaminophen; Behavior, Addictive; Drug Combinations; Humans; Nursing Staff, Hospital; Opioid-Related Disorders; Oxycodone; Professional Impairment | 2012 |
The implications of tamper-resistant formulations for opioid rotation.
Topics: Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Drug Compounding; Drug Tolerance; Humans; Morphine; Naltrexone; Opioid-Related Disorders; Oxycodone; Oxymorphone; Patient Selection | 2012 |
Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment.
Topics: Adult; Analgesics, Opioid; Chemistry, Pharmaceutical; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Prevalence; Sentinel Surveillance; Young Adult | 2013 |
Reexamine the study on abuse potential of Remoxy(®) : what was missing?
Topics: Analgesics, Opioid; Female; Humans; Male; Opioid-Related Disorders; Oxycodone | 2013 |
The heritability of oxycodone reward and concomitant phenotypes in a LG/J × SM/J mouse advanced intercross line.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Conditioning, Operant; Drug-Seeking Behavior; Female; Genetic Predisposition to Disease; Likelihood Functions; Male; Mice; Mice, Inbred Strains; Motor Activity; Opioid-Related Disorders; Oxycodone; Phenotype; Reward; Sodium Chloride | 2014 |
Who's writing the script?
Topics: Analgesics, Opioid; Canada; Delayed-Action Preparations; Drug Prescriptions; Drugs, Generic; Humans; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Risk Factors | 2013 |
Comparison of opioid doctor shopping for tapentadol and oxycodone: a cohort study.
Topics: Analgesics, Opioid; Cohort Studies; Databases, Factual; Drug Prescriptions; Female; Humans; Longitudinal Studies; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Phenols; Physicians; Retrospective Studies; Risk Assessment; Tapentadol; Treatment Outcome | 2013 |
Don't tamper with oxycodone.
Topics: Analgesics, Opioid; Canada; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drugs, Generic; Humans; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Prescription Drug Misuse | 2013 |
Response to letter by Dr. Ruan.
Topics: Analgesics, Opioid; Female; Humans; Male; Opioid-Related Disorders; Oxycodone | 2013 |
An iterative model for in vitro laboratory assessment of tamper deterrent formulations.
Topics: Chemistry, Pharmaceutical; Humans; Models, Chemical; Opioid-Related Disorders; Oxycodone; Particle Size; Substance-Related Disorders | 2013 |
Prescription for addiction?
Topics: Adult; Analgesics, Opioid; Female; Humans; Low Back Pain; Opioid-Related Disorders; Oxycodone | 2001 |
Probable relationship between opioid abuse and heroin use.
Topics: Adolescent; Adult; Analgesics, Opioid; Drug Prescriptions; Drug Tolerance; Heroin Dependence; Humans; Ohio; Opioid-Related Disorders; Oxycodone | 2003 |
OxyContin: maintaining availability and efficacy while preventing diversion and abuse.
Topics: Analgesics, Opioid; Chronic Disease; Crime; Drug and Narcotic Control; Health Services Accessibility; Humans; Opioid-Related Disorders; Oxycodone; Pain; Tennessee; United States | 2003 |
Achieving the right balance in oversight of physician opioid prescribing for pain: the role of state medical boards.
Topics: Analgesics, Opioid; Data Collection; Drug and Narcotic Control; Drug Prescriptions; Drug Utilization Review; History, 20th Century; History, 21st Century; Humans; Licensure, Medical; Opioid-Related Disorders; Oxycodone; Pain; Policy Making; Practice Patterns, Physicians'; State Government; United States | 2003 |
Medico-legal rounds: medico-legal issues and alleged breaches of "standards of medical care" in opioid rotation to methadone: a case report.
Topics: Adult; Analgesics, Opioid; Autopsy; Chronic Disease; Decision Making; Expert Testimony; Florida; Humans; Male; Malpractice; Medication Errors; Methadone; Opioid-Related Disorders; Oxycodone; Pain; Pain Clinics; Psychiatry; Quality of Health Care | 2003 |
No data to show link between opioid abuse and heroin use.
Topics: Analgesics, Opioid; Drug Prescriptions; Drug Tolerance; Heroin Dependence; Humans; Ohio; Opioid-Related Disorders; Oxycodone | 2003 |
Cutting back on high-dosage narcotics.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Arthroplasty, Replacement, Hip; Drug Administration Schedule; Female; Humans; Neoplasms; Opioid-Related Disorders; Oxycodone; Pain; Pain, Postoperative; Patient Participation | 2004 |
Drug update: Fentanyl patch abuse.
Topics: Administration, Topical; Analgesics, Opioid; Emergency Medical Services; Fentanyl; Humans; Opioid-Related Disorders; Oxycodone; United States | 2004 |
A profile of OxyContin addiction.
Topics: Adult; Analgesics, Opioid; Female; Humans; Incidence; Kentucky; Male; Opioid-Related Disorders; Oxycodone; Retrospective Studies; Substance Abuse Treatment Centers | 2004 |
Substance use histories in patients seeking treatment for controlled-release oxycodone dependence.
Topics: Adult; Alcoholism; Analgesics, Opioid; Comorbidity; Cross-Sectional Studies; Delayed-Action Preparations; Drug Prescriptions; Female; Hospitals, Psychiatric; Humans; Illicit Drugs; Male; Massachusetts; Medical Records; Opioid-Related Disorders; Oxycodone; Patient Readmission; Substance Abuse Treatment Centers; Substance-Related Disorders | 2004 |
Kentucky's pain.
Topics: Drug and Narcotic Control; Humans; Illicit Drugs; Kentucky; Narcotics; Opioid-Related Disorders; Oxycodone | 2004 |
Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats.
Topics: Animals; Avoidance Learning; Conditioning, Classical; Dose-Response Relationship, Drug; Female; Injections, Subcutaneous; Morphine Dependence; Motivation; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Orientation; Oxycodone; Rats; Rats, Sprague-Dawley; Reward; Substance Withdrawal Syndrome | 2005 |
Preoperative "fentanyl challenge" as a tool to estimate postoperative opioid dosing in chronic opioid-consuming patients.
Topics: Analgesics, Opioid; Blood Gas Analysis; Computer Simulation; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Hydrocodone; Infusions, Intravenous; Male; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Preoperative Care; Prospective Studies; Spinal Fusion | 2005 |
Non-medical use of OxyContin Tablets in the United States.
Topics: Adolescent; Adult; Child; Demography; Female; Humans; Male; Narcotics; Opioid-Related Disorders; Oxycodone; United States | 2005 |
Rush Limbaugh's path to pill addiction.
Topics: Analgesics, Opioid; Famous Persons; Humans; Male; Opioid-Related Disorders; Oxycodone; Pain; United States | 2003 |
In the grip of a deeper pain.
Topics: Analgesics, Opioid; Humans; Opioid-Related Disorders; Oxycodone; Pain; United States | 2003 |
FDA actions to prevent prescription drug abuse.
Topics: Analgesics, Opioid; Drug and Narcotic Control; Drug Approval; Drug Prescriptions; Humans; Mandatory Reporting; Opioid-Related Disorders; Oxycodone; Risk Management; Texas; United States; United States Food and Drug Administration; United States Substance Abuse and Mental Health Services Administration | 2005 |
Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
Topics: Adolescent; Adult; Age Factors; Analgesics, Opioid; Child; Cross-Sectional Studies; Drug Prescriptions; Female; Geography; Health Personnel; Health Surveys; Humans; Hydrocodone; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Prevalence; Product Surveillance, Postmarketing; Racial Groups; Risk Management; Sex Factors; Socioeconomic Factors; Surveys and Questionnaires; United States | 2005 |
Evaluating potentially aberrant outpatient prescriptions for extended-release oxycodone.
Topics: Analgesics, Opioid; Databases, Factual; Delayed-Action Preparations; Drug Prescriptions; Drug Utilization Review; Humans; Narcotics; Opioid-Related Disorders; Outpatients; Oxycodone; United States; United States Department of Veterans Affairs; Veterans | 2005 |
Use of OxyContin by adolescent students.
Topics: Adolescent; Canada; Humans; Opioid-Related Disorders; Oxycodone; Students | 2006 |
Development and preliminary experience with an ease of extractability rating system for prescription opioids.
Topics: Algorithms; Analgesics, Opioid; Cluster Analysis; Drug Compounding; Drug Prescriptions; Fentanyl; Guidelines as Topic; Observer Variation; Opioid-Related Disorders; Oxycodone; Pharmaceutical Preparations; Research Design | 2006 |
Clinical considerations in the treatment of chronic pain with opiates.
Topics: Accidents, Traffic; Alcoholism; Analgesics, Opioid; Chronic Disease; Depression; Humans; Low Back Pain; Male; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Pain | 2006 |
The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
Topics: Analgesics, Opioid; Data Collection; Delayed-Action Preparations; Drug Prescriptions; Humans; Hydrocodone; Indiana; National Institutes of Health (U.S.); Opioid-Related Disorders; Oxycodone; Poison Control Centers; Police; Risk Assessment; Risk Management; Risk Reduction Behavior; Substance Abuse Treatment Centers; Substance-Related Disorders; United States | 2007 |
Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.
Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Humans; Hydrocodone; Methadone; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Risk Assessment; Risk Management; Rural Population; Suburban Population; United States; Urban Population | 2007 |
Complete soft palate necrosis and velopharyngeal insufficiency resulting from intranasal inhalation of prescription narcotics and cocaine.
Topics: Acetaminophen; Administration, Inhalation; Adult; Analgesics, Opioid; Cocaine; Cocaine-Related Disorders; Deglutition Disorders; Drug Combinations; Female; Hearing Loss, Conductive; Humans; Necrosis; Nose Deformities, Acquired; Opioid-Related Disorders; Otitis Media with Effusion; Oxycodone; Palate, Soft; Surgical Flaps; Vasoconstrictor Agents; Velopharyngeal Insufficiency | 2007 |
Abuse deterrence focus of upcoming opioid formulations.
Topics: Analgesics, Opioid; Chemistry, Pharmaceutical; Humans; Morphine; Opioid-Related Disorders; Oxycodone; Pain; Technology, Pharmaceutical | 2008 |
Evaluation of ongoing oxycodone abuse among methadone-maintained patients.
Topics: Adolescent; Adult; Cocaine-Related Disorders; Enzyme Multiplied Immunoassay Technique; Female; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Outpatients; Oxycodone; Reagent Strips; Substance Abuse Detection; Time Factors; United States; Young Adult | 2008 |
Emotional dehiscence after successful renal transplantation.
Topics: Adult; Depression; Female; Humans; Kidney Transplantation; Mental Disorders; Opioid-Related Disorders; Oxycodone; Transplantation, Homologous | 1980 |
Iatrogenic opiate addiction: successful detoxification with clonidine.
Topics: Clonidine; Codeine; Female; Humans; Middle Aged; Opioid-Related Disorders; Oxycodone; Pain, Intractable; Substance Withdrawal Syndrome | 1980 |
Codeine and oxycodone use in patients with chronic rheumatic disease pain.
Topics: Aged; Analgesics, Opioid; Codeine; Cohort Studies; Drug Prescriptions; Female; Humans; Male; Middle Aged; Minnesota; Opioid-Related Disorders; Oxycodone; Pain; Pain Measurement; Retrospective Studies; Rheumatic Diseases | 1998 |
Granulomatous glomerulonephritis in intravenous drug users: a report of three cases in oxycodone addicts.
Topics: Adult; Female; Glomerulonephritis; Humans; Male; Opioid-Related Disorders; Oxycodone; Substance Abuse, Intravenous; Suppositories | 1998 |
Treatment augmentation with opiates in severe and refractory major depression.
Topics: Comorbidity; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Narcotics; Opioid-Related Disorders; Oxycodone; Oxymorphone; Treatment Outcome | 1999 |
Trends in medical use and abuse of opioid analgesics.
Topics: Analgesics, Opioid; Drug Utilization; Fentanyl; Humans; Hydromorphone; Meperidine; Morphine; Opioid-Related Disorders; Oxycodone; Pain; Retrospective Studies; Risk Assessment; Social Change; United States | 2000 |
The 'poor man's heroin'. An Ohio surgeon helps feed a growing addiction to OxyContin.
Topics: Analgesics, Opioid; Drug Prescriptions; Humans; Liability, Legal; Ohio; Opioid-Related Disorders; Orthopedics; Oxycodone; Pain | 2001 |
How one town got hooked.
Topics: Crime; Humans; Illicit Drugs; Kentucky; Narcotics; Opioid-Related Disorders; Oxycodone | 2001 |
Oxycodone and oxycontin.
Topics: Administration, Oral; Delayed-Action Preparations; Humans; Morphine Dependence; Neoplasms; Opioid-Related Disorders; Oxycodone; Pain; Parenteral Nutrition, Total | 2001 |
Opioid therapy for chronic painful conditions.
Topics: Analgesics, Opioid; Chronic Disease; Clinical Trials as Topic; Fentanyl; Humans; Karnofsky Performance Status; Low Back Pain; Methadone; Morphine; Opioid-Related Disorders; Oxycodone; Pain; Patient Selection; Practice Guidelines as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Time Factors | 2001 |
There is no accounting for accountability.
Topics: Analgesics, Opioid; Humans; Liability, Legal; Opioid-Related Disorders; Oxycodone; United States | 2002 |
Oxy's offspring.
Topics: Analgesics, Opioid; Female; Humans; Infant, Newborn; Maine; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Oxycodone; Pain; Pregnancy; Pregnancy Complications; United States | 2002 |
Oxycontin--misuse and abuse.
Topics: Analgesics, Opioid; Drug and Narcotic Control; Drug Prescriptions; Health Services Misuse; Humans; Massachusetts; Opioid-Related Disorders; Oxycodone | 2002 |
Chronic use of opioid analgesics in non-malignant pain: report of 38 cases.
Topics: Adult; Aged; Analgesics, Opioid; Female; Humans; Levorphanol; Male; Methadone; Middle Aged; Opioid-Related Disorders; Oxycodone; Pain, Intractable; Personality Assessment; Personality Inventory; Retrospective Studies; Risk; Time Factors | 1986 |
Atypical withdrawal syndrome (organic delusional syndrome) secondary to oxycodone detoxification.
Topics: Codeine; Delusions; Female; Humans; Middle Aged; Opioid-Related Disorders; Oxycodone; Substance Withdrawal Syndrome; Substance-Related Disorders | 1988 |